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Interleukin-10 (IL-10) is an important regulator of immune responses secreted by different cell 
types. Previous results from our group suggested that the biological effects of this cytokine 
critically depend on its cellular source. Recent studies reported IL-10 dependent immuno-
suppressive functions of a specialized subset of regulatory B cells and mast cells. These results 
relied on adoptive cell transfers, a technique which can potentially introduce artifacts. Therefore, 
we aimed to readdress these questions in independent models using IL-10 transcriptional 
reporter mice and various conditional IL-10 mutant mice. 
Findings in IL-10 reporter system suggested prominent IL-10 transcription in regulatory B cells 
upon LPS administration. Exposure of mice to contact allergen revealed robust reporter 
expression in CD8 T cells, moderate to mild reporter expression in CD4 T cells and dendritic 
cells (DC) respectively, and lack of reporter expression in B cells, mast cells and NK cells in 
allergen challenged ears. 
We generated cell-type specific IL-10 mutants by Cre/LoxP-mediated conditional gene 
inactivation. Efficiency and specificity of Cre-mediated recombination was demonstrated by 
Southern blot and PCR methods. 
Various immunogenic challenges in conditional IL-10 mutants did not reveal a role for B cell-
derived IL-10 in restraining innate TLR or T cell-dependent inflammatory responses. Likewise, 
mice with selective inactivation of the il10 gene in mast cells exhibited normal CHS responses 
and unaltered immune response to CpG oligodeoxynucleotides. On the other hand, DC-specific 
IL-10 mutants developed excessive inflammatory responses to contact allergens, while innate 
responses to TLR ligands were not altered. This indicates a non-redundant role for DC-derived 
IL-10 in contact allergy.  
Thus, the conditional IL-10 ‘‘knockout’’ mice combined with the novel transcriptional IL-10 
reporter system can serve as ideal tools to understand the cell-type specific contributions to IL-




     



































1.1 The immune system
The immune system protects us against invading microorganisms. It is composed of two parts, 
the innate immune system and adaptive immunity, which, although fundamentally different in 
the way they recognize pathogens and in their effector functions, intimately collaborate. Most 
cells of the body are capable of contributing to the innate immune response, with
types like e.g. macrophages, granulocytes and dendritic cells specializing in innate immune 
functions. An invading microorganism is first detected by a set of receptors, which recognize 
molecular structures that frequently occur in the microbial
constituent of the cell wall of all Gram
receptor (TLR)4, while microbial DNA, which differs from mammalian DNA in the low frequency 
of methylation of CpG dinuc
hypomethylated DNA, which are wide spread and conserved in the microbial world are called 
pathogen-associated molecular patterns (PAMPS) and the receptors of the innate immune 
system, which detect them are addressed as pattern recognition receptors (PRRs). A large, but 
limited, number of PRRs are known and display variable patterns of expression in different 
mammalian cell types. Upon ligand binding, PRRs signal to activate the cell and to induce rapid
release of pro-inflammatory cytokines and chemokines, which recruit phagocytic cells capable 
of destroying microorganisms, i.e. macrophages and neutrophilic granulocytes, to the site of 
pathogen invasion. In many instances, this fast innate immune respons
tissue inflammation, is sufficient to clear the infection. At least, replication and spread of the 
pathogen is retarded to some degree granting the organism more time to mount an adaptive 
immune response. Adaptive immunity is a functi
B cells and thymus-derived T cells. These cells need several days for full activation and 
development of effector cell functions. Thus, adaptive immunity is much slower than the innate 
response. However, in contrast to innate immunity, B and T cells are capable of responses, 
which are highly specific to the invading pathogen. This is possible by the random generation of 
extremely large numbers of different antigen receptor molecules by developing B and T cells
through a genetic recombination process (called VDJ recombination). This process equips each 
lymphocyte with a single, unique receptor defining the antigen
receptors specific for self-structures are largely deleted in t
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non-autoreactive lymphocytes are released into the periphery. These naïve, i.e. antigen
inexperienced lymphocytes re
and spleen, where they wait to encounter 
invasion of a pathogen, the local innate immune response activates tissue resident dendritic 
cells, which take up microbial antigen. The ligation of pattern recognition receptors by microbial 
components as well as local tissue damage provide danger signals to these cells, which induce 
dendritic cells to emigrate from the tissue into the draining lymph node and upregulate their 
antigen-presentation machinery. In the lymph node, naïve T cells with receptors t
microbial antigen presented by the dendritic cells receive activation signals, which induce 1) 
their massive clonal expansion and 2) their differentiation into armed effector T cells. While 
CD8+ cytotoxic T cells are capable of killing infected ce
macrophages in killing intracellular pathogens and provide help to the B cell response. Naïve B 
cells take up antigen that binds to their antigen receptor, process it and present it to T cells. If an 
activated T cell recognizes antigen on this B cell, the B cell gets activated, proliferates and the 
progeny differentiate into plasma cells, which secrete a soluble form of the surface antigen 
receptor, i.e. an antibody. Antibodies can bind to microorganisms and thereby label the
destruction by the complement system or phagocytes. The effectors of adaptive immunity, 
effector T cells and antibodies, thus represent lethal weapons, which are highly specific for a 
particular pathogen. The local innate immune response is less effe
as a first barrier impairing pathogen spread until the T and B cell system can respond.
While autoimmunity, i.e. immune responses falsely directed against self
recognized cause of inflammatory diseases, i
responses specifically directed against foreign structures, e.g. a pathogen, as a rule, cause 
“collateral” damage to the tissues of the host. The extent to which immune
damage occurs depends on the
immune responses must therefore be balanced such that efficient pathogen control is achieved 
with minimal “immunopathology”.
1.1.1 Immunopathology
The most important function of the immune sys
the immune system is a “double
-circulate through secondary lymphoid organs, like lymph nodes 
antigens that bind to their antigen receptor. Upon 
lls, CD4+ 
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is also marked by the risk of immuno
cells of the immune system. During immune response effectors molecules are produced to fight 
against the invading pathogens. The magnitude of this response should be controlled to protect 
the healthy cells from damage. Therefore, our system has devised ways to protect the host from 
damage by secreting various anti
the inflammatory responses by blocking the effector functions.
 
1.1.2 Interleukin- 10 (IL
In order to protect the host from “collateral” damage anti
involved in regulating and modulating the 
is the cytokine Interleukin-10 (IL
(CSIF) (Fiorentino et al., 1989).
differentiation and function of Th1 cells. Further studies revealed that IL
numerous subsets of T cells including Th1, Tregulatory cells, CD8 as well as other 
hematopoietic and non-hematopoietic 
IL-10 activity is mediated by binding to the IL
hematopoietic cell types. Upon bindi
and Tyk2 (Moore et al., 2001), which in turn activate
resulting in their nuclear translocation and modulation of gene expression (Finbloom et al., 
1995). IL-10 signaling results in inhibition of expression of pro
chemokines, adhesion molecules, down
and costimulation (Moore et al., 2001). However, IL
granulocyte, mast cell and keratinocyte growth and differentiation as well as NK
cytotoxic T cell activation (Moore et al., 2001; Fiorentino et al., 1991a, b; Mocellin et al., 2003; 
2004, Boulland et al., 1998). 
 
1.1.3 Biological functions of IL
Several in vitro studies have reported the effects of IL
presenting cells and lymphocytes are the primary targets of IL
cell populations thus regulating the Th1/Th2 balance.
-pathology i.e. damage to host tissues inflicted by effector 




vigor of any immunological response. One such 
-10), first described as cytokine synthesis inhibitory factor 
 IL-10 was initially identified as a Th2-derived factor suppressing 
-10 can be secreted by 
cell types. 
-10 receptor (IL-10R) complex expressed by most 
ng of IL-10, the receptor activate the tyrosine kinases Jak1 
 the transcription factors STAT1, 3 and 5 
-inflammatory cytokines, 
-regulation of proteins involved in antigen
-10 is also known to enhance 
-10  
-10 on different cell populations. Antigen 
-10. IL-10 acts directly on these 
 Th1 cells are particularly known to be
 




-cell and CD8+ 
 
essential for effective cell-mediated immunity,
triggers, whereas Th2 cells are responsible for effective production of IgE, IgA and IgG in 
particular for neutralizing microorganisms and their toxins (Romagnani, 1995). IL
their anti-inflammatory functions by inhibiting the IFN
suppression of IL-12 synthesis in accessory cells. It also acts as
factor for B cells, which is important in the adequate defence against intestinal parasites, 
neutralization of bacterial toxins, and in local mucosal defense (Romagnani, 1995).
IL-10 down-modulates the antigen prese
Fiorentino et al., 1991a, b; Romagnani, 1995) and inhibit pro
and thus represent a potential suppressor of cellular immunity.
 
Effects on Myeloid antigen-presenting cells
IL-10 exerts the following effects on monocytes and macrophages: i) modulate 
soluble mediators regulating inflammation and tissue repair. ii) down regulate antigen 
presentation to T cells iii) enhances phagocytosis. More specifically, I
production of pro-inflammatory mediators by monocytes and macrophages such as endotoxin
and IFN-γ induced release of IL
1991a; Fiorentino et al., 1991a). In addition, it enhances the production of anti
mediators such as IL-1RA and soluble TNF
Secondly, IL-10 down regulates the expr
costimulatory molecules such as CD86 and adhesion molecules such as CD58 (de Waal 
Malefyt et al., 1991b; Willems et a
monocytic production of IL-12, 
responses (D’Andrea et al., 1993). Besides these suppressive functions
phagocytic activity of monocytes and macrophages (Buchwald et al., 1999).
Effects on T cells: 
Although the most important effects of IL
modulation of antigen presenting cell function, IL
cells IL-10 inhibits proliferation 
et al., 1993; Groux et al., 1996). The presence of IL
 cell mediated inflammation against infectious 
-γ secretion by T cells particularly via the 
 growth and differentiation 
ntation machinery (De Waal Malefyt et al., 1991a, b; 
-inflammatory cytokine production 
 
: 
-1β, IL-6, IL-8, GM-CSF, and TNF-α (de Waal Malefyt et al., 
-α receptors (Jenkins et al., 1994; Hart et al., 1996). 
ession of MHC-class II molecules and also 
l., 1994; Creery et al., 1996). Moreover, IL
an essential mediator for the development of 
-10 seem to be indirect and are mediated by 
-10 also has direct effects on T cells. In 
and production of IL-2, IFN-γ as well as IL
-10 during the activation of T cells results in 
 
-10 mediates 
 In addition, 
the production of 
L-10 inhibits the 
- 
-inflammatory 
-10 inhibits the 
inflammatory Th1 
, IL-10 favors the 
 
CD4 
-4 and IL-5 (Del Prete 
 
the development of a regulatory phenotype characterized by weak proliferation, absence of IL
production and specific cytokine profile (IL
studies have demonstrated that IL
regulatory cells highlighted in 
activate CD8 cells (Groux et al., 1998; Santin et al., 2000).
           
Figure 1.1 Effects of IL- 10 on the Th1/Th2 
Several autoimmune conditions display a
cytokine pattern by inhibiting 
costimulatory molecule expression on professional APCs 
2003 review) 
Effects on Natural killer cells
IL-10 exerts stimulatory effect
stimulating the production of cytokines such as IFN
amplifies the IL-2 induced proliferation of NK cell
augments the ability of IL-18 to stimulate NK cells (Cai et al., 1999).
Effects on other immune cells
IL-10 exerts weak stimulatory effects on B cells. It favors the proliferation and differentiation of B 
cells towards plasma cells as well as IgM synthesis (Levy and Brouet, 1994;
1995). It plays a role in the Ig class switching 
and IgA2 secretion (Defrance et al.,
macrophages, IL-10 also inhibits the
-10+, IFN-γ+, IL-4-, IL-5-) (Groux et
-10 is essential for maintaining FoxP3 expression in T 




 type 1 cytokine pattern. IL-10 reverses this and promotes 
pro-inflammatory cytokine expression as well as
(adopted and modified from Asadullah et al., 
 
s on NK cells. It favors the cytotoxic activity of these cells by 
-γ, GM-CSF and TNF
s (Carson et al., 1995). Moreover, IL
 
 
by inhiibiting IgE production
 1992; Jeannin et al., 1998). Like in monocytes and 
 production of pro-inflammatory cytokines
 
-2 
 al., 1996). Recent 
a Th2 
 MHC class II and 
-α. Furthermore, it 
-10 
 Rousset et al., 
 and inducing IgA1 
 and chemokine 
secretion by granulocytes (Cassatella et al., 1993; Kasama et al., 1994) and 
of anti-inflammatory mediators (IL
synthesis of pro-inflammatory mediators in eosinophils and mast cells (Takanaski et al., 1994; 
Arock et al., 1996). In combination with IL
and Befus, 1997). 
Effects on epithelial cells 
The effect of IL-10 on keratinocytes
lack of IL-10 effects on KC proliferation, cytokine formation, and expression of surface 
molecules with regard to immune modulation. It is to be noted the discrepancies could be due to 
the experimental approaches and contamination of cell cultures potentially with other 
which respond to IL-10 application. 
by keratinocytes and therefore the 
2002). 
Taken together, IL-10 is a multi
effects serving as immune modulatory agent which critically determines
any immune response. 
1.1.4 Effects of IL- 10 in animal models of infection and autoimmunity
A large body of data from various animal models of disease and autoimmunity has shown a 
critical role of IL-10 in preventing exaggerated immune responses. 
il10 gene in IL-10-/- mice resulted in overwhelming immune responses to different stimuli 
emphasizing the central regulatory function of this cytokine. IL
exaggerated immune responses to enteric antigens resulting in chronic entero
al., 1993). In addition, IL-10-
evident from experiments addressing 
doses of LPS, which are well tolerated by control mice. Serum analysis of LPS
mice showed elevated levels of IFN
immunity. IL-10-/- mice also showed dysregulation
(croton oil) (Rennick et al., 1997)
 
-1RA). Another effect of IL-10 is the inhibition of LPS
-3 and IL-4, IL-10 favors the growth of mast cells (Lin 
 
 (KC) is still a matter of debate. In vitro
In vivo studies demonstrated a lack of IL
observed effects are likely of indirect 
-functional cytokine which has both stimulatory and inhibitory 
 the
Complete inactivation of the 
-10-/- mice spontaneously 
deficient mice are extremely susceptible to endotoxic shock as 
the response to LPS stimulus. IL
-γ and TNF-α indicating uncontrolled activation of innate 
 of cutaneous immune responses




 studies suggested 
cell types 
-10R1 expression 
nature (Seifert et al., 
 overall outcome of 
 
develop 
-colitis (Kuhn et 
-10-/- mice die of low 
- injected IL-10-/- 
 to irritants 
Exogenous administration of IL
responses in many diseases such as experimental autoimmune encephalomye
et al., 1994), diabetes mellitus (Pennline et al., 1994), experimental endotoxemia (Gerard et al., 
1993) and arthritis (Persson et al., 1996; Tanaka et al., 1996).
conflicting results, the majority o
10 in mice ameliorates inflammatory and auto
IL-10 also remained an attractive target in limiting tumor progression; however the functions of 
IL-10 in tumors still remains controversial.
inhibitory effects for IL-10 in different tumor models (Asadullah et al., 2003). 
IL-10 plays a dual role in response to infectious triggers. Prolonged over expression of IL
inhibit the protective immune response to infections (Moore et al., 2001).
susceptibility to infections and modifications in immune responses to intracellular bacteria and 
parasite were reported in cases of IL
hand, protective effects of exogenous IL
reported in case of complete 
(Chmiel et al., 2002). Exogeneous IL
experimental group B streptococcal arthritis (Puliti et al., 2002) and in gastrointestinal helminth 
infections (Schopf et al., 2002).
Similar stands of dual property have been reported in conditions of autoimmunity and allergy. 
Increased levels of IL-10 was reported in 
(SLE) (Park et al., 1998), systemic sclerosis (Hasegawa et al., 1997), bullous pemphigoid 
(Schmidt et al., 1996) and exogenous 
the treatment of these conditions. On the other hand, deficient IL
in uncontrolled inflammation in certain disease conditions such as psoriasis (Asadullah et al., 
1998), rheumatoid arthritis (Narula, 2000), alle
other non-atopic eczemas (Kang et al., 1994), chronic inflammatory bowel disease (Kuhn et al., 
1993) and multiple sclerosis (Barrat et al., 2002).
be beneficial in treating these
 
 
-10 proved beneficial in limiting uncontrolled inflammatory 
 Although
f studies suggest that therapeutic application of 
-immune diseases.  
 Available literature suggests both progressive and 
-10 over expression (Yamakami et al., 2002). On the other 
-10 in limiting uncontrolled inflammatory responses 
il10 deficient mice exposed to pseudomonas bacterial infection 
-10 also limits the immune patholo
 
patient samples of systemic lupus erythematosus 
application of IL-10 antagonists proved to
-10 levels significantly resulted 
rgic contact dermatitis (Schwarz et al., 1994) and 
 Exogenous administration of IL
 overwhelming inflammatory conditions. 
 
litis (EAE) (Rott 






gy associated with 
 be beneficial in 
-10 proved to 
1.1.5 IL-10 in therapy and prophylaxis
Past clinical trials addressed effects of exogenous 
Crohn’s disease, rheumatoid arthritis, psoriasis, hepatitis C
seemed to be quite heterogeneous in diffe
Crohn’s disease, rheumatoid arthritis, chronic hepatitis C infections gave unsatisfactory and 
disappointing results, whereas IL
explanations were attributed for the disappointing outcomes such as 
in the target tissue, phase of the disease (IL
depending on the actual state of the disease), polymorphisms exhibited at the level of receptor 
and cytokine promoter, time and route of administration of IL
better understanding of biological 
may help designing new strategies for IL
1.1.6 Biological relevance of IL
infection and autoimmunity
As outlined above, IL-10 is secreted by wide variety of 
most hematopoietic cells, raising
different cellular sources.  
Functions of IL-10 derived from T cells
Most known subsets of T cells were reported to be capable of secreting IL
selective inactivation of the 
responses highlighting the importance of T cells as a cellular source of
T cell-specific IL-10 knock out mice suffered from exaggerated T cell responses to 
to contact allergens and displayed spontaneous intestinal inflammation. The extent to which 
these T cell responses were deregulated w
and mice with complete IL-10 
which showed enhanced tissue inflammation upon treatment of the skin with a chemical irritant 
that induces a local innate immune response, the T cell
responses to skin irritation. These findings demonstrated that T cell
 
administration of IL-10 in the treatment of 
 and HIV infection. The results 
rent disease conditions. All trials of IL
-10 proved beneficial in the treatment of psoriasis. Several 
insufficient levels of IL
-10 may stimulate or suppress 
-10. These 
effects of IL-10 in disease and homeostasis is 
-10 based therapeutic approaches. 
-10 derived from particular cell types
 
cell types including epithelial cells and 
 the question of differential functions fulfilled by IL
 
il10 gene in all T cells featured severe deregulation of immune 
 IL
as indistinguishable in the T cell
deficiency (IL-10-/-) mice. However, in contrast to 
-specific mutants displayed normal 
-derived IL
 
-10 therapy in 
-10 
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-10 was critical for  
control of T cell responses but dispensable for limitation of innate resp
2004). In order to define whether within the T cell compartment the subset of regulatory T cells 
is an important source of IL-10, the gene was inactivated selectively in FoxP3 expressing cells. 
These mutants showed similar phenotypes a
inflammation was in general less severe suggesting that inflammatory T cell responses were 
under control by IL-10 from both regulatory and conventional T cells (Rubtsov et al., 2008). In 
line with this observation, Jankovic et al.
populations regulate themselves in their response to intracellular parasites by production of IL
10. Importantly, in these infection models, significant IL
(non-Th1) cell types. However, the cytokine produced by Th1 cells was critical for regulation of 
the response. In certain other inflammatory conditions, CD8
source of IL-10 contributing to immune modulation (Jarnic
Functions of IL-10 from dendritic cells and macrophages
Suppression of activation of antigen presenting cells and inhibition of their presentation 
machinery by IL-10 is regarded central to IL
possible, that these cells themselves produce the IL
role for macrophage derived IL
demonstrated in mice deficient for 
deregulation of this response 
macrophage-derived IL-10 has been shown to 
model of L. major (Padigel et al., 2005). Similarly, in the EAE model of multiple sclerosis, 
monocytes were found to produce IL
regulatory cells that modulate
Several recent studies suggest
more than T cells as a cellular source of IL
expressing IL-10 and other anti




s the pan T cell-specific knockout mice, however, 
 and Anderson et al. demonstrated that Th1 cell 
-10 production was observed b
+ cells were also reported to be 
ki et al., 2006; Noble et al., 2006).
 
-10 mediated control of T cell responses. It seems 
-10 which controls 
-10 in limiting inflammatory responses to LPS have been 
il10 in macrophages (Siewe et al., 2006) whereas no 
was observed in T cell-specific il10-
influence disease progression in a low dose 
-10 and TGF-β leading to the differentiation of Th2 and T
 adaptive immune responses in the brain (Weber et al., 2007). 
 that maintenance of intestinal homeostasis could depend on 
-10. A recent study points to 
-inflammatory molecules in the lamina propria
 
 





their function. A clear 
deficient mice. Also, 
 
CD11b+ myeloid cells 
, which induce 
Functions of IL-10 from NK cells
NK cells are another potential innate source of IL
defense against viruses (Biron et 
cell-derived IL-10 is not completely established but several reports hav
may display regulatory activity in pregnancy, during tumor development and chronic hepatitis C 
infection (as reviewed in Hedrich et al., 2010). NK 
providing protection against immuno
2009). 
Functions of IL-10 from B cells
IL-10 is also expressed by B cells and recent evidence
roles for B cell-derived IL-10. 
al., 1992; Duan et al., 2006). As described in more detail below, a subset 
cells) were recently reported to negatively regulate immune responses in different disease 
conditions such as chronic colitis (Mizoguchi et 
(Mauri et al., 2003), type 1 diabetes (Hussain et al., 2007), contact hypersensitivity (CHS) 
(Yanaba et al., 2008) and experimental autoimmune encephalomyelitis
2002, Matsushita et al., 2008). The
secretion of IL-10.  
Functions of IL-10 from mast cells
The expression of IL-10 by mast cells was well established
addressed immunoregulatory 
(kitW/W-v and kitW-sh/W-sh) and their r
mice. (IL-10-/-) This study reported 
regulation (Grimbaldeston et 
role of mast cell-derived IL-10 in UV
2011). Mast cells via secretion of IL




-10. NK and NKT cells are critical to host 
al., 1989; Arase et al., 2002).The biological significance of NK 
cells as a source of IL
-pathology associated with MCMV infection (Lee et al., 
 
 suggests important immune regulatory 
Both, B1 and B2 cells were reported to express I
B regulatory cells (B10 
al., 2002), collagen-induced arthritis (CIA) 
 (EAE) (Fillatreau et al., 
 negative regulatory function was found to depend on their
 
 by Lin and Befus. A recent study
functions of mast cells using conventional mast cell
econstitution with mast cells from wild type 
functional significance of mast cell-derived IL
al., 2007). A study published this year showed
- induced immune suppression (Chacon
-10 can modulate their own activation in an autocrine 
 
e suggested NK cells 
-10 were implicated 




or IL-10- deficient 
-10 in immune 
 an indispensable 
-Salinas et al., 
1.1.7 Generation of cell type
In order to investigate the role of IL
systems, we used the Cre/loxP recombination system and selectively deleted 
various cell types. These mice were generated by crossing the IL
C57BL/6 background, Roers et al., 2004) with different Cre transgenic lines su
(Lee et al., 2001; Wolfer et al., 2001), LysM
1997), Mcpt5-Cre (Scholten et al., 2008)
macrophage-, B-cell-, mast-cell
            
Figure 1.2 Generation of cell type
The IL-10FL line was bred with different Cre 





-specific IL-10 mutants 
-10 derived from individual cell types
-10FL 
-Cre (Clausen et al.,1999), CD19
, CD11c-Cre (Caton et al., 2007
- or DC-specific IL-10 mutants, respectively
-specific IL-10 mutants 
expressing lines to generate T-cell
 
 
 in independent 
the il10 gene in 
line (generated in the 
ch as CD4-Cre 
-Cre (Rickert  et al., 
) to generate T-cell-, 
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-, B-cell-, macrophage-, 
1.2 Contact allergy  
1.2.1 Introduction 
Allergic contact dermatitis is a common inflammatory skin
occupational health problem. 
the pathophysiology of the condition. (i) 
agents that activate the skin’s innate immune system. (ii) 
represents a T cell-mediated delayed
substances leading to the activation of effector and memory T cells. 
sensitizing compound results in redness, papules and vesicles, followed by scaling and dry skin.
Several known contact allergens, which chemically react with 
the skin are designated as ‘haptens’. They in general are 
which bear lipophilic residues that enable them to cross through the corneal barrier and 
establish covalent association with cu
that activation of haptens via oxidation or by other means is essential for the transformation of 
the haptens to highly reactive metabolites (reviewed in Vocanson et al., 2009). Examples 
strong haptens are DNFB (2,
dinitrochlorobenzene), and TNCB
robust inflammatory skin response and are able to sensitize more than 90% of individuals after 
a single skin contact. Weak haptens such as dyes, preservatives, perfumes, metal ions or drugs 
are devoid of skin toxicity and display weak inflammatory properties. Weak haptens can induce 
sensitization only in small proportion of the individuals and the mec
induce specific T cell-mediated skin inflammation are u
2009). 
1.2.2 Pathophysiology
Most knowledge on the pathophysiology
various contact allergens. Experimental induction of contact allergy in mice is designated as
 
 disorder that represents an important 
Two main types of contact dermatitis are recognized, according to 
the irritant dermatitis is the response of the skin to 
the allergic contact dermatitis 
-type hypersensitivity response to environmen
Repeated e
self proteins upon penetration into 
highly reactive substances 
taneous proteins (‘‘haptenization’’)
4-dinitroflurobenzene), oxazolone, DN
 (Trinitrochlorobenzene). Strong haptens potentially elicit a 
hanisms 
nknown (reviewed in Vocanson et al., 
 of CHS 




xposure to the 
 
most of 
. It is also suggested 
for 
CB (2,4-
by which they 
sensitizing mice to 
 
‘‘contact hypersensitivity’’ (CHS). 
inflammatory condition. From the existing literature it is recognized the 
is marked by two distinct phases namely (i) sensitization or ‘‘afferent phase’’ (ii) elicitation or 
‘‘efferent’’ phase and less understood resolution phase (reviewed in Vocanson et al., 2009).
(i) Sensitization phase 
The sensitization phase of CHS,
occurs on the first encounter with the hapten 
specific CD4+ and CD8+ T cells in the skin draining lymph nodes and migration 
into the skin. The non-immunogenic hapten 
immunogenic peptides that are presented 
skin draining lymph nodes (reviewed in Vocanson et a
DCs is promoted by tissue resident cells
6, IL-12 upon exposure to the sensitizing compound
necrosis factor alpha (TNF-α) and 
may contribute to LC activation and migration (reviewed in Grabbe and Schwarz, 1998).
step has no clinical consequence in the majority of cases but
the site of contact 5-15 days after hapten encounter (reviewed in Vocanson et al., 2009).
(ii) Elicitation phase 
Upon re-exposure to the same hapten in sensitized individuals 
presented on many cell types on MHC class I and on MHC class I and II 
Allergen-specific T cells get activated after recognition of these peptides and secrete a broad 
spectrum of pro-inflammatory mediators. 
effector cells in the development of 
inflammatory response via production of 
48h in mouse. The inflammation lasts for few days
down-regulating pathways (ex: C
decreases the inflammation (reviewed in Vocanson et al., 2009).
 
 
CHS is a classical DC/LC dependent T
pathophysiology
 also referred to as the “afferent” or “induction” phase that 
subsequently leading to 
reacts with cutaneous proteins leading
by the APCs of the skin such as 
l., 2009). The activatio
 that secrete inflammatory cytokines such as IL
. In addition other cytokines such as tumor 
granulocyte-macrophage colony stimulating factor (GM
 may induce skin inflammation at 
haptenated peptides are 
on the APC of the skin. 
Studies up to date suggests CD8 cells as the main 
CHS and CD4 cells as regulatory cells dampening the 
IL-10. The efferent phase takes 72h in man, and 24
-weeks and by various yet uncharacterized 
D4+CD25+ T regulatory cells) (resolution phase) progressively 
 
 
-cell mediated skin 
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activation of hapten- 
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 to 
DCs and LCs in the 






1.2.3 The role of IL
regulation of the CHS response
As described above, the CHS re
mechanisms, since IL-10 deficient mice are characterized by enhanced CHS responses. 
Selective inactivation of the 
indistinguishable from that seen in 
indispensable for control of CHS 
T regulatory cells as well as non
by selective inactivation of the 
As indicated in the introductory paragraph, regulatory B cells were reported to modu
spectrum of inflammatory responses
is regulated by B cells (Watanabe et al., 2007)
be dependent on IL-10 production by B cells
al., 2008). Studies in CD19
signalling showed an increased magnitude of CHS response to DNFB and FITC. Analysis of 
hapten treated ears and sensitized l
with decreased IL-10 expression. Adoptive transfer experiments suggested a subset of marginal 
zone B cells characterized by CD21
response via IL-10 secretion.
subset of B cells termed “B10” 
secretion of IL-10 to supress 
from transgenic mice overexpressing human CD19 (
transmembrane signals, proliferate more 
humoral immune response to T dependent antig
cells. In these mice, the CHS 
(CD1dhiCd5+) from sensitized mice normalized the 
mice whereas the B10 cells from IL
contrast, conventional B cells (non
response. These findings suggested an important role of IL
 
-10 derived from different cell types 
 
sponse is effectively counter-regulated by IL
il10 gene in T cells results in a deregulation of CHS that is 
IL-10-/- mice. This indicates that IL
(Roers et al., 2004). Within the T cell compartment IL
-Treg T cells contributes to regulation of CHS as demonstrated 
il10 gene in FoxP3+ T cells (Rubtsov et al., 2008
 in mice and humans.The contact hypersensitivity response 
. This regulatory effect of B cells was described to 
 (Yanaba et al., 2008, Dilillo et a
-deficient mice characterized by compromized B cell receptor 
ymph nodes showed an increased Th1/Tc1 cytokine profiles 
hiCD23lo expression to negatively regulate the CHS 
 Recently, Yanaba and colleagues have shown 
characterized by expression of CD1d
the delayed hypersensitivity response to contact allergens
hCD19Tg mice) are hyperresponsive to 
strongly in response to mitogens, generate elevated 
ens and show increased frequencies of B10
response was found decreased. Adoptive transfer of B10
enhanced ear swelling response 
-10-/- mice did not suppress CHS upon adoptive transfer. In 
-B10 cells, B220+CD5-) did not suppress the enhanced CHS 








l., 2010, Bouaziz et 
that specialized 
, CD5 and prominent 






In addition to T and B cells also mast cells are discussed as source of IL
control of CHS. Grimbaldeston and colleagues 
mast cell-deficiencies (KitW/W-
and exhibit enhanced and prolonged CHS responses. However, kit mutant mice also feature in 
addition to their mast cell-deficiency also other phenotypic abnormalities. The 
exhibit macrocytic anaemia, reduced numbers of bone marrow and blood neutrophils, sterility 
and reduced numbers of interstitial cells of Cajal. Kit
but have increased numbers of bone marrow and blood neutrophils, enlarged spleens and m
cardiomegaly (as reviewed in Galli and Tsai, 2010). 
reconstituted with in vitro differentiated mast cells, in order to demonstrate that a particular 
phenotype is caused by the lack of mast cells. Reconstitution of ki
resulted in reduction of the CHS to normal levels,  
wild type bone marrow derived mast cells cultured 
IL-10 failed to normalize the enha
2008). These findings suggested
cell-dependent inflammatory responses. 
In addition to IL-10 from lymphocytes and mast cells, 
attention as a source of IL-10 relevant for the control of CHS. LC
sampling the foreign material 
(reviewed in Cavani, 2008). LC
DNFB-induced CHS (Igyarto et al., 2009). Very few studies assessed the role of 
dermal DCs in CHS. DCs 
hypersensitivity possibly inducing
1.3 Inflammatory bowel disease 
1.3.1 Introduction 
Inflammatory bowel disease (IBD) represents a heterogenous group of diseases characterized 
by chronic or recurrent intestinal in
Crohn’s disease is characterized by granulomatous inflammation which can occur along the 
entire length of the intestinal tube but is most frequently encountered in the terminal ileum.
addressed this question using mouse models of 
v and KitW-sh/W-sh). These mouse lines profoundly lack mast cells 
W-sh/W-sh mice are neither
Therefore, these mice are routinely 
t mutant mice with mast cells 
as demonstrated after adoptive transfer of 
in vitro, whereas the mast cells deficient for 
nced ear inflammation (Grimbaldeston et
 an immune suppressive role for mast-
 
dendritic cells have received much 
s and DCs
and danger signals and mounting appropriate immune responses
-derived IL-10 was shown to contribute to the regulation of
engineered to overexpress IL-10 were found to inhibit contact 
 T cells to adopt a tolerogenic phenotype (Besche et al., 2010).
 
flammation including Crohn’s disease and ulcerative colitis. 
-10 relevant for the 
KitW/W-v mice 
 anaemic nor sterile, 
ild 
 al., 2007, Galli et al., 
cell-derived IL-10 in T 







Ulcerative colitis affects exclusively the colon and the inflammatory process is non
granulomatous. While an important pathogenic role of deficiency for IL
unambiguously demonstrated in these two conditions, an additional entity of very sev
pediatric IBD was recently shown to be caused by defective IL
(Glocker et al., 2009). Numerous mouse models for IBD have been described and can be 
divided into those with spontaneous development of intestinal inflamma
induced by genetic manipulation, chemically induced colitis models and those that depend on 
transfer of cell populations into immune deficient hosts. Manipulation and over expression of 
different genes have resulted in intestinal infla
(IL-10-/-) spontaneously develop inflammatory bowel disease as a result of an uncontrolled Th1 
response to luminal bacterial antigens 
characterized by overproduction of TNF
depend on the microbial milieu the animals are exposed to, i.e. depending on the composition of 
the intestinal flora, intestinal inflammation can be very severe or even completel
1.3.2 The role of IL- 10 
of intestinal inflammation 
While the importance of IL-10 in the maintenance of intestinal immune homeostasis was clearly 
demonstrated by the phenotype of IL
cytokine have been a matter of debate. 
increased susceptibility to colitis both 
colitis (Werner Muller, Manchester, personal communication). A
cells from normal mice into lymphocyte deficient mice leads to the development of progressive 
Th1 cell-mediated IBD (Morrissey et al., 1993; Powrie et al., 1993). The co
CD45Rblow T cells together with the potentially pathogenic T cells prevents the intestinal 
inflammation due to the IL-10 and TGF
within this cell pool (Powrie et al., 1993; Asseman et al., 1999, Powrie et al., 1996). 
CD4+CD25+FoxP3+ Treg and “Tr1” cells are involved in the regulation of the intestinal 
inflammation, given that these cells can prevent and cure experimental colitis via IL
TGF-β dependent pathways (Izcue et al., 2009). Recent studies suggest that 
also a site for Treg development (Uhlig et al., 2006; Maynard et al., 2007) where IL
-10 or IL
mmation. Mice with complete deficiency for IL
(Kuhn et al., 1993). This deregulated immune response is 
α. Penetrance and severity of this phenotype critically 
derived from different cell types in the control 
 
-10-/- mice, the relevance of different cellular sources of the 
Mice selectively deficient for IL
in spontaneous (Roers et al., 2004) and induced model of 
 transfer of CD4
-β dependent activities of regulato
-
-10 has not been 
ere form of 
-10 receptor genes 
tion, those that are 
-10 
y absent. 
-10 in T cells showed 
+ CD45RB high T 
-transfer of CD4+ 
ry T cells (Tr cells) 
-10 and 
the intestine is 
-10  
producing Treg cells accumulate within the lamina propria, mesenteric lym
An important role of Treg-derived IL
of the il10 gene (Rubtsov et al., 2008
inflammation of the animals is less severe compared
that IL-10 from Treg cells and conventional T cells significantly contributes to immune regulation 
in the intestine. Administration of 
incidence of colitis induced by pathogenic T cells. However, the protection by exogenous IL
administration was only transient whereas transfer of CD45RB 
lasting protection. This may refle
source of IL-10 and can only partially be restored by exogenous IL
 
Published studies suggest that B cell
Mizoguchi and colleagues have demonstrated that there is an increased
B cells of mesenteric lymph node and colonic lamina propria associated with development of 
intestinal inflammation in TCR
CD21intCD62lowIgMintCD23hi (unlike the splenic m
expression of CD21hiCD6hiIgM
mesenteric lymph node, produces IL
inflammation. These cells, primarily act by down
than by influencing the T helper responses. 
cells termed “B10” cells,  (CD1d
sodium sulfate (DSS)-induced mode
The role of mast cells in influencing the gut 
reports suggests an increased mast cell number in the mucosa of the ileum and colon of 
patients with IBD with substantial changes in mast cell expression of TNF
P. Elevated levels of histamine and tryptase levels were detected in mucosa of IBD patients 
suggesting mast cell degranulation in the pathogenesis of IBD (reviewed in Bischoff
of the studies addressing a potential role of mast
conducted in vitro and don’t allow to decide upon the 
The intestine and associated lymphoid tissues 
macrophages, conventional CD11c
-10 was demonstrated in mice with Treg
). These mice spontaneously develop IBD. The gut 
 to the disease of IL
recombinant IL-10 (rIL-10) showed beneficial effects on the 
low CD4+
ct that the protective effects largely depend on the 
-10. 
-derived IL-10 contributes to gut 
 expression of CD1d on 
α KO mice. This subset of B cells characterized by 
arginal zone B cells which show
hiCD23-) appears during the inflammatory process in the 
-10 and suppresses the progression of t
-regulating IL-1 and STAT3 activation rather 
A recent study has demonstrated that regulatory B 
hiCD5+)  can negatively influence gut homeostasis in the dextran 
l of colitis via IL-10 production (Yanaba et al., 2011).
immune homeostasis is still unclear. Available 
-cell-derived IL-10 in immune regulation were 
in vivo relevance of IL
homes various innate cells such as 
hi and plasmacytoid DCs (reviewed in Coombes and Powrie, 
 
ph nodes and spleen. 
-specific inactivation 
-10-/- mice suggesting 
-10 






α, IL-6 and substance 
 2006). Most 
-10 from mast cells. 
 
2008). Various subpopulations of DC are localized in P
and throughout the small intestinal and col
patches produce higher levels of IL
has shown that β-catenin signaling in 
regulatory responses in the intestine wherein various anti
acid, IL-10 and TGF-β contribute to the tolerogenic phenotype of the 


























eyer’s patches, mesenteric lymph node
onic lamina propria. Activated 
-10 than splenic DCs (Iwasaki et al., 1999). A recent 
DCs regulates the balance between the inflammatory and 




DCs from Peyer’s 
study 
 (Manicassamy et al., 
e 
1.4 Objectives 
Interleukin-10 (IL-10) is an important anti
hematopoietic and non-hematopoietic cell types. 
laboratories suggested that 
functions of this immunomodulatory cytokine. The aim of this thesis was to delineate the 
contributions of individual cell t
immune responses.  
The first task was to identify cell types producing IL
IL-10 transcriptional reporter mice.
A second task was to determine the 
for the regulation of immune responses by analysis of cell type
Relation of findings in the reporter system to the phenotypes in our conditional IL














-inflammatory cytokine secreted by various 
Earlier results from our own and other 
the cellular source of IL-10 critically determines the biological 
ypes to the control of innate and T cell-mediated inflammatory 
-10 in responses to the various stimuli using 
 
in vivo relevance of IL-10 released from different sources 
-specific IL-
-specific effects of IL-10 in immune regulation.
 
10 knockout mice. 
-10 mutants 
 
2.1 Utilization of IL
cellular sources of IL
As described in detail in the introduction part, numerous c
10. In order to better understand IL
it was important to obtain an overview of cell types producing IL
defined stimuli. One option to 
intracellular immune-staining for IL
of sensitivity and antibody specificity. Therefore, transcriptional IL
were used. These mice were generated 
inserting the IRES-GFP cassette 
was regulated by the endogenous 
in-vivo IL-10 production both in lymphoid and myeloid cell types. 
cassette did not significantly interfere with the regulation of the 
Vert-X mice did not display any 
However, mRNA expression of GFP and IL
qualitative differences in translation and secretory processes of IL
Nevertheless, the reporter system seemed to faithfully report the IL
immune stimuli as addressed in 
studies to identify cellular sources
used for the experiments were homozygous for 
Figure 2.1 R epresentation of IL
The Vert-X IL-10 transcriptional reporter mouse was generated by inserting 
ribosomal entry site-enhanced green fluorescent protein) cassette 
endogenous pA of the il10 gene locus by gene targeting. Numbers 1
polyadenylation tail; UTR untranslat
promoter. (figure taken and modified from 
 
-10 reporter mice (Vert- X) to identify 
-10 in vivo 
ell types are capable of producing IL
-10-mediated counter-regulation of inflammatory responses
-10 in response to various 
generate this information is flow cytometric de
-10 protein. This approach, however, is limited by problems 
-10 reporter mice (Vert
in the collaboration group of Dr. C. karp, Cincinnati, 
into the intact il10 locus such that the expression of the gene 
il10 promoter. Vert-X mice were shown to faithfully report 
The insertion of the reporter 
il10 gene, since homozygous 
signs of spontaneous colitis (as seen in IL
-10 allele were quite variable.This may be due to the 
-10 and GFP protein.
-10 expression under various 
Madan et al., 2009. Therefore, we utilized the mice in our 
 of the cytokine under inflammatory conditio
the Vert-X allele. 
-10 transcriptional reporter mice 
an
between the fifth exon and the 
-5 represent exons of 
ed region.  il10 gene expression was driven by endogenous IL








-10 deficient mice). 
 
ns. All animals 
 
 IRES-eGFP (internal 
il10 gene; pA- 
-10 
2.1.1 Systemic inflammatory response to lipopolysac charide
In order to identify cellular sources of IL
CD1dhiCD5+ B cell subset (“B10” cells) is characterized by prominent IL
the Vert-X reporter mouse line. We challenged Vert
48h post-challenge for eGFP expression
found prominent reporter expression in 
results were obtained for peritonea
                                
Figure 2.2 In vivo analysis of IL
Homozygous Vert-X (Vert-X+/+) mice were challenged with saline (n=1) or 50µg LPS i.p. (n=1) and single 
cell suspensions of the spleen were analyzed for eGFP express
for CD1d and CD5 expression. Black and grey graphs represent saline control and LPS
mice, respectively. Arbitrary gates are set indicating %GFP
cells. Similar results were obtained in two independent experiments.
 
-10 upon LPS challenge and to determine whether the 
-10 production, we used 
-X mice with LPS and analyzed splenic cells 
 by flow cytometry. As reported by
B10 cells in comparison to conventional B cells. Similar 
l lavage cells upon LPS stimulation (data not shown).
-10 reporter expression upon LPS challenge 
ion. CD19+ cells were gated and analyzed 








- injected Vert-X+/+ 
 
2.1.2 Splenic B cells after allergen (Oxazolone) ch allenge of the skin
Yanaba et al. reported that IL
cell-dependent inflammatory responses to contact allergens.
defective B cell receptor signaling as well as B cell
swelling response upon DNF
an immunosuppressive role for B cells in this delayed type of hypersensitivity response. 
et al. performed adoptive transfer
depended on IL-10 as B10 cells 
              
 
Figure 2.3 Ex vivo analysis of spleen cell
challenge 
Homozygous Vert-X (Vert-X+/+) mice were 
(n=1) as described in Yanaba et al 
and analyzed for eGFP expression by flow cytometry. CD19
identified as CD1dhiCD5+ cells. eGFP expression in 
Black and grey graphs represent vehicle control and oxazolone treated mice, respectively. Mice 
sensitized but unchallenged were 
as did the vehicle controls (data not shown)
experiments. 
-10 produced by B10 regulatory cells is relevant for suppressing T 
 CD19-/- mice 
-deficient mice show
B sensitization and challenge (Watanabe et al., 2007) suggesting 
s of B10 cells which revealed that the suppressive function 
from complete IL-10 knock out (IL-10-/-) mice failed to 
 
 IL-10 reporter expression following 
sensitized and challenged with vehicle (n=1) or
.48h post-challenge, splenic single cell suspensions were prepared 
+ cells were gated and B10 cells were 
 vehicle- and allergen-treated mice are displayed. 
also analyzed and yielded identical eGFP expression in splenic B cells 




ed exaggerated ear 
Yanaba 




suppress the ear swelling response. 
levels in B10 regulatory cells from the spleen 2 days following oxazolone challenge
skin and speculated that splenic B10 cells contribute to regulation of the allergic response in a 
IL-10- dependent fashion. In order 
sensitized and challenged the IL
way as described by Yanaba et al.
cells for their  eGFP expression 48h post
any change in reporter activity in allergen
2.1.3 IL-10 reporter expression
DNFB-challenged ears
In order to identify local cellul
and challenged IL-10 reporter mice with DNFB. At various time points, single cell suspensions 
of ear skin were prepared and the hematopoietic cell 
reporter expression. The scheme for CHS is shown in figure 2.4. In order to exclude non
hematopoietic cells from our analysis, we used the CD45 surface marker to delineate cells of 
hematopoietic origin.                  
                                  
Figure 2.4 Scheme for contact hypersensitivity 
Homozygous Vert-X (Vert-X+/+) mice were
On day 5, the mice were challenged with 0.2% 
Following challenge, ear skin single cell 
and IL-10 reporter expression at indicat
Of note, the authors showed increased IL
to reproduce this finding in an independent model, we 
-10 transcriptional reporter mice with oxazolone
 and analyzed the splenic conventional and B10 
-challenge. As shown in figure 2.3, we did not observe 
- treated versus untreated mice. 
 in hematopoietic cells infiltratin
 of Vert-X mice 
ar sources of IL-10 in allergen-challenged ear skin, we sensitized 
populations were analyzed for IL
                                                                                                                
 
 sensitized with 0.5% DNFB on the shaved abdomen at day 0.
DNFB on the dorsal and ventral surface of the 
suspensions were prepared and analyzed for inflammatory cells 
ed time points by FACS. 
 
-10 transcript 
 on the ear 










  A   
Figure 2.5 Numbers of hematopoietic cells infiltrating 
Homozygous Vert-X (Vert-X+/+) mice 
On day 5, the mice were challenged with 0.2% 
challenge, ear skin single cell suspension
numbers of CD45+ cells 24-120h post
skin cells. Black and grey bars represent
bars represent mean±SD. Student t
As shown in figure 2.5, there was a 2
challenged versus vehicle treated ears after allergen 
with the increase in the ear thickness measured at each of the indicated time points. 
subsequent experiment, various cell types such as B and T cells, mast cells, NK cells, and 
were analyzed for their cell numbers and IL
2.1.4 IL-10 reporter expression in ear skin B cells after DN FB 
challenge 
As B cells, in particular B10 
hypersensitivity (CHS) response in an IL
addressed IL-10 reporter expression by B cells in the inflamed ear skin. 
Figure 2.6 shows the gating of B cells in ear skin cell suspensions as CD45
Numbers of B cells in the ear skin were lo
               B         
the ears following DNFB
were sensitized with 0.5% DNFB on the shaved abdomen at day 0. 
DNFB on the dorsal and ventral surface of ears. Fol
s were analyzed at indicated time points by FACS
-challenge. (B) Relative numbers of CD45
 vehicle control and allergen challenged mice, respectively.
-test was used to calculate significance. ***p<
-3 fold increase in the percentage of CD45
application. This increase corresponded 
-10 reporter expression.  
regulatory cells, were reported to suppress
-10- dependent fashion (Yanaba et al., 2008), we first 
 
w but increased in response to the DNFB 
 
    










. (A) Absolute 
+ cells among total ear 
 Error 
0.001 
+ cells in the 
In the 
DCs 
 the contact 
+CD19+ cells. 
 
challenge. We did not detect any IL
points after allergen challenge.
      
Figure 2.6 Ear skin B cells during
Homozygous Vert-X (Vert-X+/+) mice were
On day 5, the mice were challenged with 0.2% 
challenge, ear skin single cell suspensions were
Identification of B cells as CD45
time points after allergen challenge. 
positive cells before and after DNFB challenge.
allergen challenged mice, respectively. 
calculate significance.*p =0.01- 0.05
2.1.5 IL-10 rep orter expression in mast cells of DNFB
Mast cells are best known for their effector functions in anaphylaxis and other immediate 
hypersensitivity reactions. However, mast cells were also reported to limit DNFB
by production of IL-10 (Grimbaldeston et al., 2007). Therefore, it was important to address IL
reporter expression by mast cells in inflamed ear skin.
 
-10 reporter expression in B cells at any of the indicated time 
 
 the elicitation phase of contact hypersensitivity
 sensitized with 0.5% DNFB on the shaved abdomen at day 0.
DNFB on the dorsal and ventral surface of ears. Following 
 analyzed at indicated time points by FACS. 
+CD19+ double positive cells. (B) CD45+CD19+ cell 
(C) Absence of IL-10 reporter expression in 
 Black and grey bars represent









numbers at indicated 
CD45+CD19+ double 
 vehicle control and 
-test was used to 
 
- induced CHS 
-10 
              
Figure 2.7 Ear skin mast cells during 
Homozygous Vert-X mice (Vert-X
On day 5, the mice were challenged with 0.2% 
challenge, ear skin single cell suspensions were
Identification of mast cells as c
respective isotype control stainings. 
challenge. (C) Absence of IL-10 reporter expression in 
and grey bars represent vehicle control and allergen challenged mice, respectively.
mean±SD. 
The mast cells were identified in ear skin cell suspensions as c
As shown in the figure 2.7 (B), no significant differences were observed in mast cell numbers in 
vehicle control and allergen treated ears at various time poi
FcεR+ mast cells positive for e
2.1.6 Expression of IL
challenged ears 
It is well known that contact hypers
CD4 and CD8 T cells contribute to
are reported to be the main effector cells, while CD4 cells possess a regulatory function 
(Vocanson et al., 2009). We were inte
for their eGFP expression in DNFB
the elicitation phase of contact hypersensitivity
+/+) were sensitized with 0.5% DNFB on the shaved abdomen at day 0. 
DNFB on the dorsal and ventral surface of ears. 
 analyzed at indicated time points by FACS. 
-kit+FcεR+ double positive cells. Mast cells were gated based on the 
(B) Mast cells numbers at indicated time points afte
mast cells before and after allergen painting. 
-kit+FcεR+
nts. We did not detect any c
GFP expression before or after allergen application. 
-10 repo rter in T cell subsets in DNFB
ensitivity is a classic T cell-mediated immune reaction. Both 
 the pathophysiology of the disease wherein the CD8 cells 
rested to look at both CD4 and CD8 








 Error bars represent 




T cell numbers and 
                 
Figure 2.8 CD4 T cell numbers 
DNFB-challenged ears 
Homozygous Vert-X (Vert-X+/+) mice were
On day 5, the mice were challenged with 0.2% 
challenge, ear skin single cell suspensions were
Identification of CD4 T cells as CD45
control and challenged ears at indicated time poin
used to calculate significance
CD45+CD4+ double positive T cells
mouse (without eGFP cassette) was
and vehicle treated ears were analyzed at each of the indicated time points. However, as an example, 
graphs were shown only for 24h. Of note, similar eGFP expression was seen in vehicle treated ears at 
other indicated time points (data not shown). Black and grey graphs represent vehicle control and 
allergen challenged mice, respectively
cells (E) Relative percentage of IL
bars represent vehicle control and allergen
and IL-10 reporter expression of CD45 +CD4+ double positive cells 
 sensitized with 0.5% DNFB on the shaved abdomen at day 0.
DNFB on the dorsal and ventral surface of ears. 
 analyzed at indicated time points by FACS. 
+CD4+ double positive cells. (B) Numbers of CD4 
ts. Error bars represent mean±SD. Student t
.*p =0.01-0.05, ***p<0.001. (C) IL-10 reporter expression
. Percent  eGFP+ cells among CD45+CD4+ cells
 used to set the eGFP gate. The WT mouse 
 (D) Absolute numbers of IL-10 reporter expressing 
-10 reporter expressing cells among total CD4 cells. B







T cells in vehicle 
-test was 
 in gated 
 are shown. The WT 
(without eGFP cassette) 
CD45+CD4+ 
lack and grey 
As shown in figure 2.8, allergen challenge resulted in a significant increase in CD4 T cell 
numbers at different time points in comparison to the vehicle treated ears.
considerable number of CD4 T cells in unchallenged ears. There was always a          baseline 
IL-10 reporter expression in unchallenged ears and a moderate increase 
after allergen challenge.  
In contrast to CD4 T cells, CD8 T cells were almost completely absent in vehicle treated ears 
(figure 2.9). However, CD8 T cell numbers
various time points. IL-10 reporter expression 
the eGFP expression gradually 
48h (about 16% of the cells were positive for the reporter expression among the total CD8 cells) 
gradually decreasing thereafter
2.1.7 IL-10 reporter expression in dendritic cells of DNFB
ears 
Like in other tissues, the skin harbors professional a
cells (LC) reside in the epidermis, a distinct population of DC is 
the skin, usually addressed as “dermal dendritic cells”. Both subsets take up antigens invading 
the skin and, upon appropriate activation, migrate to skin draining lymph nodes where they 
prime antigen-specific T cells. Recent studies show 
2008) and LC (Bobr et al., 2010) in regulating skin immune responses. In part
IL-10 was reported as an essential source of IL
(Igyarto et al., 2009). We ana
investigated the IL-10 reporter expression.
There was a significant increase in the
to the vehicle-treated ears. Considerable numbers of 
marginal increase in the IL-10 reporter expression was seen 
among CD45+CD11c+ double positive cells
numbers and their IL-10 reporter expression are 
 
 
 significantly increased in allergen
was undetectable in vehicle control ears whereas 
increased with time in allergen-treated ears reaching 
.  
ntigen presenting cells. While L
localized 
an essential role for DC (Fukunaga et al., 
-10 dampening the ear swelling response 
lyzed DC cell numbers in the inflamed ear skin and also 
 
 DC cell number in the allergen-painted 
DCs were found in control ears. A 
with about 1% of 
 24, 48 and 72h post-challenge
shown in the figure 2.10. 
 
 We observed a 
in reporter expression 
-challenged ears at 
a peak at 
-challenged 
angerhans 
in the lower strata of 
icular, LC-derived 
ears in contrast 
eGFP+ cells 
. The absolute DC cell 
                    
Figure 2.9 CD8 cell numbers and IL
DNFB-challenged ears 
Homozygous Vert-X (Vert-X+/+) mice were
On day 5, the mice were challenged with 0.2% 
challenge, ear skin single cell suspensions were
Identification of CD8 T cells as CD45
control and challenged ears at indicated time poin
used to calculate significance.*p =0.01
gated CD45+CD8+ double positive T cells
WT mouse (without eGFP cassette) was
cassette) and vehicle treated ear
example, graphs were shown only for 24h. Of note, no IL
treated ears at any of the indicated time points. Black and grey graphs represent vehicl
allergen challenged mice, respectively
cells (E) Relative percentage of IL
bars represent vehicle control and allergen
-10 reporter expression of CD45 +CD8+ double positive cells 
 sensitized with 0.5% DNFB on the shaved abdomen at day 0.
DNFB on the dorsal and ventral surface of ears. 
 analyzed at indicated time points by FACS. 
+CD8+ double positive cells. (B) Numbers of CD8
ts. Error bars represent mean±SD. Student t
-0.05, **p=0.001-0.01 ***p <0.001. (C) IL-10 
. Percent eGFP+ cells among CD45+CD
 used to set the eGFP gate. The WT 
s were analyzed at each of the indicated time points. However, as an 
-10 reporter expression was seen in vehicle 
 (D) Absolute numbers of IL-10 reporter expressing 
-10 reporter expressing cells among total CD8 cells. B







 T cells in vehicle 
-test was 
reporter expression in 
8+ cells are shown. The 
mouse (without eGFP 
e control and 
CD45+CD8+ 
lack and grey 
                   
Figure 2.10 DC cell numbers and IL
cells in DNFB- challenged ears
Homozygous Vert-X (Vert-X+/+) mice were
On day 5, the mice were challenged with 0.2% 
challenge, ear skin single cell suspensions were
Identification of DCs as CD45+CD
challenged ears at indicated time poin
calculate significance.*p =0.01
CD45+CD11c+ double positive DCs
mouse (without eGFP cassette) was
and vehicle treated ears were analyzed at each of the indicated time points. However, as an example, 
graphs were shown only for 24h. Of note, no IL
at any of the indicated time points. Black and grey graphs repr
challenged mice, respectively (D)
Relative percentage of IL-10 reporter expressing cells among total CD11c cells. B
represent vehicle control and allergen
-10 reporter expression among CD45 +CD
 
 sensitized with 0.5% DNFB on the shaved abdomen at day 0.
DNFB on the dorsal and ventral surface of ears. 
 analyzed at indicated time points by FACS. 
11c+ double positive cells. (B) Numbers of DCs
ts. Error bars represent mean±SD. Student t
-0.05, **p=0.001-0.01. (C) IL-10 reporter expression
. Percent eGFP+ cells among CD45+CD11c+ cells
 used to set the eGFP gate. The WT mouse (without eGFP cassette) 
-10 reporter expression was seen in vehicle treated ears 
esent vehicle control and allergen 
 Absolute numbers of IL-10 reporter expressing 
-treated mice, respectively.  
 
 




 in vehicle control and 
-test was used to 
 in gated 
 are shown. The WT 
CD45+CD11c+ cells (E) 
lack and grey bars 
2.1.8 IL-10 reporter expression in natural killer cells (NK)  of DNFB
challenged ears 
Recently, natural killer (NK) cells 
Leary et al., 2006). NK cells are proposed to be an important cell type mediating inflammatory 
processes. On the other hand, 
We analyzed NK cell numbers and IL
data shows a significant increase in NK cell numbers 24
figure 2.11, the vehicle treated control ears were nearly devoid of NK cells. 
at 72h post-challenge and decreased thereafter
NK cells of control or allergen
                              
Figure 2.11 NK cell numbers and 
Homozygous Vert-X (Vert-X+/+) mice were
On day 5, the mice were challenged with 0.2% 
challenge, ear skin single cell suspensions were
Identification of NK cells as CD45
indicated time points after allergen challenge. 
double positive cells before and after DNFB challenge.
allergen challenged mice, respectively. 
calculate significance.*p =0.01-0.05
gained attention in the context of contact hypersensitivity (O’ 
NK cells are capable of producing IL-10 (Vigano et al., 2001)
-10 reporter expression in DNFB
-120h post-challenge. As shown in 
. No IL-10 reporter expression 
- treated ears. 
IL-10 reporter expression in allergen- treated 
 sensitized with 0.5% DNFB on the shaved abdomen at day 0.
DNFB on the dorsal and ventral surface of ears. Following 
 analyzed at indicated time points by FACS. 
+Nk1.1+ double positive cells. (B) CD45+Nk1.1
(C) Absence of IL-10 reporter expression in 
 Black and grey bars represent





-challenged ears. Our 
NK numbers peaked 
was detected in 
 
ear skin  
 
(A) 
+ cell numbers at 
CD45+Nk1.1+ 
 vehicle control and 
-test was used to 
2.2 Generation of cell
In order to understand the in vivo
regulation, we generated various cell
recombination system. The IL
al., 2004) and bred with different Cre 
Mcpt5-Cre (Scholten et al., 2008) and
cell- and dendritic cell-specific IL
2.2.1 Demonstration of efficiency and cell type
gene inactivation 
The efficiency and cell type-specificity of Cre
was demonstrated using two different approaches. First, Southern blot analysis of DNA 
extracted from various tissues was done to exclude significant
Second, single cells were sorted into PCR tubes by flow cytometry and their 
analyzed by single target amplification. 
2.2.1.1 Southern blot analysis of
CD19-Cre mice  
The B cell-specificity and ef
analysis of DNA isolated from FACS
loxP-flanked fragment was observed in splenic B cells from IL
no or only insignificant deletion was observed in splenic CD3 T cells, peritoneal macrophages, 
or tail biopsies from the same animals. Thus, inactivation of the 
mice is efficient in B cells and is not detected in other cell types by Southern blo
(Madan et al., 2009). 
The Southern analysis for other two lines namely IL
will be performed in the near future.
 
 
-type specific IL- 10 mutant mice
 functions of IL-10 derived from different cell types, 
-type specific IL-10 mutants using the Cre/LoxP 
-10FL mice was generated in the C57BL/6 
expressing lines such as CD19-Cre (Rickert et al., 1997), 
 CD11c-Cre (Caton et al., 2007) to generate B cell
-10 knock out mice, respectively. 
-specificity of 
-mediated deletion of the loxP
 deletion in other cell populations.
 
 il10 gene inactivation in IL
ficiency of Cre-mediated deletion was veri
-sorted leukocyte populations. Complete deletion of the 
-10FL/FL CD19
il10 gene in IL





background (Roers et 
-, mast 
the il10 
-flanked il10 gene 
 
il10 locus was 
-10FL/FL  
fied by Southern blot 




2.2.1.2 Establishment of single target amplificatio n of the 
various conditional IL
A powerful technique allowing quantitative analysis of genetic modifications in rare cells in the 
amplification of the locus of interest from large numbers of single cells, individually sorted into 
PCR tubes by FACS (single cell 
the genomic DNA of those cells yields genetic information at single cell level. 
single cell PCR approach is outlined in figure 2.12 
the first round PCR products were
amplification. The resulting fragment size representing floxed 
Figure 2. 12 Single cell PCR approach for the inve
il10 gene inactivation in conditional mutant mice
(A) Scheme for the nested PCR amplification of the 
prepared from spleen, peritoneal lavage or skin and enriched for rare cell population if needed. Different 
subsets of hematopoietic cells were identified using suitable surface markers and single ce
into 0.5ml thin-walled PCR tubes for the nested PCR reaction. Primers labeled 1, 3
sequences upstream or downstream of the
within the loxP-flanked fragment
deleted situation are indicated. Black and grey arrows 
second round PCR, respectively. 
deleted situation after nested PCR on FACS sorted cells. The right and left most lanes are t
molecular marker. FL and  denote the floxed and deleted state
 
-10 mutants  
deposition). Two-rounded, nested single target amplification of 
(A). In order to avoid unspecific amplifica
 further amplified with internal primers in a second round of 
and deleted situation is
      
stigation of efficiency and 
 
il10 locus. Single cell suspension of the cells were 
 loxP flanked exon 1 of the il10 locus. Primer 2 and 5 bind 
. The primer binding sites and expected amplicons
represent the primers involved in the first and the 
(B) Agarose gel electrophoresis of products representing the floxed o
 of the il10 gene,
 
il10 locus in 
The strategy for 
tion, 
 shown in 
 
cell-type specificity of 
lls were sorted 
, 4 and 6 bind 




figure 2.12 (B). The specific bands were excised and sequenced 
sequences exactly matched the expected sequence. Generally, the effi
ranged between 30-60% and the possible explanation for the efficiency to fall below 100% could
be attributed to factors such as failure in sorting single cell into the tube, degradation of DNA 
(strand breakage) or may be due to failure in amplification (inaccessible DNA).
 2.2.2 B cell- specific inactivation of the 
In order to prove the cell type-
B regulatory (B10) cells characterized by expression of CD1d and CD5 as described by Yanaba 
et al., 2008, splenic conventional B cells and B10 
and Cre-negative littermate control
using CD19 beads. 
The enriched fraction was stained for CD19, CD1d and CD5 surface markers in order to 
distinguish between conventional B cells 
stained for CD3 to identify T cells. CD19
and CD5 staining. Single cells within the indicated gates were sorted 
subjected to nested PCR as explained in figure 2.12
collected to validate the results of the nested PCR. In addition, tubes with all second round PCR 
ingredients but without first round product
controls’’). The results of nested PCR are shown in table 2.
Fourteen single conventional B cells but also 
cells always yielded only the fragment reflecting the deleted state 
cells sorted from the same animal yielded 
negative control animals gave “floxed” products only






ciency of single cell PCR 
il10 gene 
specific inactivation of the il10 gene in B cells and in particular the 
cells were isolated from IL
 mice and were enriched for B cells by magnetic cell sorting 
and B10 regulatory cells. The flow through fraction was 
+ cells were gated and displayed according to CD1d 
. As controls, tubes without cells were 
 served as PCR controls (represented as 
2.   
twenty two single CD1dhiCD5
of the gene 
the “floxed” product only. IL
. In all cases, the sorting controls and water 
 
 





into PCR tubes and 
‘‘water 
+ (B10) regulatory 




                        
Figure 2.13 Efficiency and specificity of Cre
regulatory cells  
(A) Single cell suspensions of the spleen were prepared and magnetically enriched for B cells using 
CD19 beads. The cells were then stained for CD19, CD1d and CD5 surface markers to identify 
conventional B cells and B reg (B10) cells. Dot plot shows FSC/SSC, CD19
stainings for CD1d and CD5 among CD19 gated cells (left to right). The blue 
sorting gates for B10 and conventional B cells (Non
gate were sorted into PCR tubes and were subjected to nested PCR to amplify the 
CD3+ T cells were also analyzed in parallel
enrichment procedure, CD19+ B220
using the indicated gates.  
In order to obtain a more quantitative estimate
intended to analyze samples containing higher numbers of sorted cells. We first asked the 
question whether the single cell PCR could faithfully detect small numbers of “undeleted” cells 
among a majority of cells carrying deleted 
were obtained from IL-10FL/FL CD19
 
 
-mediated deletion in conventional and CD1d
+ gate, the isotype control and 
and red box indicates the 
-B10), respectively. Single cells from the mentioned 
. (B) Using the same protocol but without 
+ B cells and CD3+ T cells from IL-10FL/FL CD19
 of the efficiency of gene inactivation in B cells
il10 loci. To this end splenic single cell suspensions 




il10 locus. As controls, 
exempting cell 
-Cre+ mice were sorted 
 we 
 double positive B  
cells and CD3+ T cells as indicated in the figure 2.13
cells were sorted into individual tubes. In addition, small numbers of T cells were sorted into 
tubes, which already contained sorted B cells. All tubes were subjected to single cell PCR as 
described above. 
        
Table 2.1 Distribution of PCR products after nested PCR
Using the protocol outlined in section 2.13, splenic single cells from IL
CD19+B220+ double positive B cells and CD3
shown in the table. Results tabulated shows number of tubes positive for either “deleted”or “floxed” or 
both products. “No product” signifies absence of both floxed and deleted fragment. Sorting controls 
represent tubes without sorted cells but handled in 
controls are PCR control tubes containing all the ingredients of the second round PCR reaction except 
the aliquot of the first round PCR reaction.
The majority of these tubes were positive for 
the “floxed” T cell product). In particular, among six tubes containing 10 B cells and 1 T cell, only 
one did not yield the “floxed” product. Taking into account the limited reliability of single cell 
deposition it can be concluded that few non
majority of deleted alleles with a high sensitivity.
 (B). Using these gates 
 
-10FL/FL
+ T cells were sorted in the ratio of 1:10 (T cells:B cells) as 
an identical way during the sort procedure. Water 
 
both PCR products. (the “deleted” B cell but a
-deleted IL-10 alleles can be detected among a 
 Therefore, tubes containing multiple
 
50, 30 or 10 B or T 
 
 CD19-Cre+ containing 
lso 
 
conventional B cells or B10 cells from 
containing 10 B cells each were positive for PCR products. In all cases, only the product 
representing the deleted locus was obtained. Considering the results of the control experiments 
it can be concluded that with a high probability, non
sample of 60 B cells. The efficiency of deletion of the loxP
be close to 100% in B cells. Nine tubes containing 10 T cells each yielded a product. In all 
cases, this was the “floxed” 
various cell populations which showed absence of Cre
populations analyzed, this data support the B cell
10FL/FL CD19-Cre mice.                                  
 Table 2.2 PCR products obtained from splenic cells
Using the protocol outlined in section
negative littermate control mice 
numbers of tubes positive for “deleted”, 
floxed and deleted fragment. Sorting controls represent tubes without sorted ce
identical way during the sort procedure. Water controls are PCR control tubes containing all the 





IL-10FL/FL CD19-Cre+ mice were analyzed. 
-deleted (“floxed”) alleles were absent in this 
-flanked can therefore be expected to 
product only. Together, with published Southern blot analysis of 
-mediated deletion in all non
-specificity of inactivation of the 
 
  
 2.12, splenic single sorted cells from IL-10FL/FL
were analyzed for conditional il10 gene inactivation. 
“floxed” or both products. “No product” signifies absence of both 
 
Six of ten tubes 
-B cell 
il10 gene in IL-
 CD19-Cre+ and Cre-
The table shows 
lls but handled in an 
 
2.2.3 Selective inactivation of th
2.2.3.1 Cre-mediated deletion in peritoneal mast cells
In order to analyze the role of mast cell
step was to demonstrate the cell type
Mcpt5-Cre mice. Since mast cells comprise a significant fraction of cells in peritoneal lavage 
fluid, suspensions from peritoneal lavage were stained for c
cells were gated as c-kit+IgE+
as F4/80 or B220 positive cells
and analyzed for Cre-mediated recombination of the loxP
2.3, deletion occurred only in mast cells, but not in macrophages or B cells. No deletion was 
detected in any of the cell type in Cre
based assay.  
                  
Figure 2.14 Sorting of single peritoneal mast cells of 
investigation of Cre- mediated deletion of the 
Peritoneal lavage cells were prepared and mast cells were stained for c
positive mast cells were sorted into 0.5
strategy described in 2.2.1.2. The left most dot plot shows the isotype control for the respective antibodies 





e il10 gene in mast cells
 
-derived IL-10 in immune counter
-specific inactivation of il10 in mast cells
-Kit, IgE, B220 and F4/80.
 double positive cells while macrophages and B cells were gated 
, respectively. Single cells within the indicated gates were sorted 
-flanked il10 locus. As shown in table 
-negative control mice emphasizing the fidelity of the PCR
IL-10FL/FL Mcpt5 Cre + mice
il10 gene 
-kit and IgE. c
 ml thin walled PCR tubes and subjected to nested PCR using the 
ypes, B220+ B cells and F4/80
 
 
-regulation, the first 
 of IL-10FL/FL 
 The mast 
-
 
 for the 
-kit+ IgE+ double 
+ macrophages 
               
 
Table 2.3 Distribution of PCR products after nested  PCR.
Peritoneal lavage cells were collected and sorted for mast cells, macrophages and B cells from IL
Mcpt5-Cre+ and Cre -negative littermate control mice. Results tabulated shows number of tubes positive 
for either “deleted” or “floxed” products. “No product” signifies absence of both floxed and deleted 
fragment. Sorting controls represent tubes without sorted cell
sort procedure. Water controls are PCR control tubes containing all the ingredients of the second round 
PCR reaction except the aliquot of the first round PCR reaction.
2.2.3.2 Cre-mediated deletion in skin mast
In addition to demonstrating deletion in peritoneal mast cells, ear skin mast cells were isolated 
IL-10FL/FL Mcpt5-Cre+ mice and tested for cell type
the mast cell-specific IL-10 knock
responses of ear skin it was necessary to determine whether the mast cells in the skin delete 
the loxP-flanked il10 gene in a similar way as observed in the peritoneal cavity. Single cell 
suspensions of ear skin were generated by enzymatic digest from IL
Cre-negative control mice. Single cells were sorted into PCR tubes
Mast cells were identified as c
using the recommended isotype controls. As control cell type, T cells identified as CD45
 
 
s but handled in an identical way during the 
 
 cells  
-specific inactivation of the 
-out line were to be analyzed for delayed type hypersensitivity 
-10
 and 




il10 gene. Since, 
FL/FL Mcpt5-Cre+ and 
analyzed for deletion. 
d 
+CD4+  
were also sorted and analyzed. The sort ga
results are shown in table 2.4.
               
Figure 2.15 Sorting of single ear skin mast cells of 
of Cre- mediated deletion of the 
An ear skin cell suspension was prepared and mast cells were identified by c
staining. c-kit+FcεR+ double positive mast cells and CD45
0.5 ml thin walled PCR tubes and subjected to nested PCR using the strategy described in 2.2.1.2. The 
left most dot plot shows the isotype control for the respective antibo
skin. CD45+CD3+ double positive T cells served as control cell types.
                       
Table 2.4 Distribution of PCR products after nested  PCR
An ear skin cell suspension was prepared and sorted for mast 
Cre+ and Cre-negative control mice. Results tabulated shows number of tubes positive for either “deleted” 
or “floxed” products. “No product” signifies absence of both floxed and deleted fragment. Sorting controls 
represent tubes without sorted cells but handled in an identical way during the sort procedure. Water 
controls are PCR control tubes containing all the ingredients of the second round PCR reaction except 
the aliquot of the first round PCR reaction.
tes are indicated in figure 2.15
 
IL-10FL/FL Mcpt5 Cre + mice
il10 gene 
+CD3+ double positive T cells  were sorted into 
dies used to identify mast cells in the 
 
. 
cells and T cells from IL
 
 
 and nested PCR 
 
 for the investigation 
-kit and FcεR surface 
 
-10FL/FL Mcpt5- 
In line with results from peritoneal lavage, the mast cells in the skin 
efficiently and in a cell type-specific 
Cre+ mice. As expected, no deletion was detected in any cell 
(only floxed fragment). These results show that the deletion is restricted to mast cells. Thus 
these mice are useful for the investigation of the potential role of mast cell
immune counter-regulation. 
2.2.4 Selective inactivation of 
 2.2.4.1 Cre-mediated deletion in splenic DC subsets of 
CD11c-Cre+ mice 
In order to demonstrate DC-specific 
CD11c-Cre+ mice for FACS sorting of 
DCs and conventional dendritic cells. The plasmacytoid 
with intermediate CD11c expression. The conventional 
the CD11c surface marker. The sort gates were established using the recommended isotype 
controls as shown in figure 2.17. As control cell types, splenic CD19
were also sorted. The results of 
As evident from the table 2.5, both sub
only the “deleted” fragment while no deletion was detected in B and T cells from the same mice. 
The Cre-negative littermate control
The sorting and water controls gave no product validating the outcome of the nested PCR. This 
result demonstrates that the inactivation of the 






manner with no deletion observed in T cells from the same 
type of Cre-
il10 gene in dendritic cells (DC)
il10 inactivation, splenic cells were isolated 
DC subsets. CD11c is expressed on both plasmacytoid 
DCs were identified as mPDCA
DCs are marked by high express
+ B cells and CD3
the nested PCR are shown in table 2.5. 
-sets of DCs from IL-10FL/FL CD11c
s showed no deletion in any of the haematopoietic cell types. 




 negative control mice 






+ T cells 
-Cre+ mice yielded 
DCs and is not 
Figure 2.16 Sorting of single splenic DCs of 
mediated deletion of the il10 gene
A single cell suspension of the spleen was prepared and enriched for different subsets of DC using pan
DC beads. The enriched fraction was stained for mPDCA and CD11c surface markers to identify the 
plasmacytoid DCs and conventional dendritic cells. The le
respective surface markers whereas the middle dot plot shows the staining for DC subsets. The sort 
gates are indicated as mPDCA for plasmacytoid 
the mentioned gate were sorted into PCR tubes and subjected to nested PCR using the strategy 
described in 2.2.1.2. As controls, CD19
deletion.  
2.2.4.2 Cre-mediated deletion in skin DC
In addition to demonstrating the conditional inactivation of 
spleen, we were interested to show the deletion in ear skin as that is the site of allergen 
application in the contact hypersensitivity assay. Single cell s
prepared by enzymatic digest. In order to exclude the other non
the CD45 surface marker to delineate the cells of hematopoietic origin. Cells double positive for 
CD45 and a lineage specific cell surfa
skin were identified as CD45
cells are shown in the fig 2.17
control cell population. Five cells were sorted into each tube and analyzed by single cell PCR. 




IL-10FL/FL CD11cCre+ mice for the investigation of Cre
 
ft most dot plot shows the isotype control for 
DCs and CD11c for conventional 
+ B cells and CD3+ T cells were also sorted and analyzed for 
 
il10 in different subsets of DC in the 
uspensions of ear skin were 
-hematopoietic cells we used 
ce marker were identified and sorted. The DC in the ear 
+CD11c+ double positive cells and the gates for sorting of single 






DCs. Single cells from 
                     
Table 2.5 Distribution of products 
Splenic FACS sorted single cells from IL
were analyzed for conditional il10 
“floxed” products are displayed. “No product” represents abs
Sorting controls represent tubes without sorted cells but handled in an identical way during the sort 
procedure. Water controls are PCR control tubes containing all the ingredients of the second round PCR 
reaction except the aliquot of the first round PCR reaction.
                                                                                                       
Figure 2.17 Cre-mediated deletion in ear skin DC
An ear skin single cell suspension was prepared and 
positive cells. Sort gates for CD45
plot shows isotype staining. Single cells within this gate
subjected to nested PCR using the strategy described in 2.2.1.2. CD45
served as control cell type. 
amplified from splenic DCs and control cells
-10FL/FL CD11c-Cre+ and Cre-negative littermate control mice 
gene inactivation. Number of tubes positive either for “deleted” or 
ence of both deleted and floxed fragment. 
 
 
DCs were identified as CD45
+CD11c+ double positive DCs and T cells are shown. The left most dot 







-walled PCR tubes and 
 double positive T cells 
Table 2.6 Distribution of products 
An ear skin single cell suspension was prepared and sorted for 
Cre+ and Cre-negative control mice. Numbers of tubes positive either for “deleted” or “floxed” products are 
displayed. “No product” represents absen
represent tubes without sorted cells but handled in an identical way during the sort procedure. Water 
controls are PCR control tubes containing all the ingredients of the second round PCR reaction ex
the aliquot of the first round PCR reaction.
In line with the results obtained from splenic DCs, the DCs in the skin of IL
mice inactivate il10 gene with high efficiency. All 18 tubes containing 5 DCs positive
product yielded only the product representing the deleted state of the locus. Tubes containing T 
cells from the same skin sample yielded “floxed” product
close to 100% of CD45+CD11c
observed in cutaneous T cells from the same mice. The Cre
yielded the floxed fragment representing 
firmly show the deletion of the 
 
 
amplified from skin DCs and control cells
DCs and T cells from IL
ce of both deleted and floxed fragment. Sorting controls 
 
s only. Thus, the deletion 
+ skin dendritic cells of IL-10FL/FL CD11c-Cre+ 
-negative control mice always 
the undeleted situation. Taken together, our results 







 for a PCR 
occurs in 
mice with no deletion 
 
2.3 Innate immune responses to TLR ligands in mice with 
inactivation of the il10
It is well established that IL
production in models of endotoxic shock. IL
(Berg et al., 1995) compared to wild type controls demonstrating the important role of IL
the regulation of the TLR4 response. However, the cell types produci
the response to LPS remains unclear. Earlier experiments in T cell
role for T cell-derived IL-10 in systemic or local immune challenge to LPS (Roers et al., 2004; 
Siewe et al., 2006). Experiments in 
IL-10 transcription in B cells (Madan et al., 2009) after 
Therefore, we challenged the B cell
ligands such as LPS, CpG 
addition, we scored the mice
discharge and diarrhea; 0-3 scale indicating the severity of the clinical signs 0
phenotype; 1-mild; 2-moderate; 3
It has also been shown earlier, 
cutaneous administration of CpG 
limiting this response. In wild type animals t
mainly comprised of macrophages 
severe with numerous neutrophils recruited into the lesion. Macrophage
mice showed only a moderate immune response like wild type controls. 
showed that the mouse macrophage
Therefore, it was surprising that the macrophage
immune deregulation. Similar results were obtained in T cell
al., 2006) demonstrating that the IL
source in limiting the immune response to CpG
may depend on IL-10 from other cellular sources
In order to address this question
challenged sub-cutaneously with CpG oligodeoxynucleotides.
 gene in different cell types 
-10-/- mice show increased mortality and deregulated cytokine 
-10-/- mice succumbed to 20-fold lower doses of LPS 
ng 
-specific mutants revealed no 
Vert-X reporter mice have identified 
in vivo LPS and CpG challenge. 
-specific IL-10 mutants systemically with different TLR 
and Poly (I:C) and analyzed the for serum cytokine profile
 for macroscopic endotoxin effects (lethargy, pilo
-severe) and survival. 
that IL-10-/- mice show excessive local in
oligonucleotides demonstrating the relevance of IL
he inflammatory infiltrate at the site of CpG injection 
while in IL-10-/- mice the inflammation was much more 
s are capable of producing IL-10 upon CpG treatment. 
-specific il10 inactivation did
-specific IL-
-10 from macrophages and T cells are not the relevant 
 DNA. These findings suggest 
 such as mast cells or DC





the IL-10 that controls 






-specific IL-10 mutant 
In vitro experiments 
 not cause any 
10 mutants (Siewe et 
that the regulation 
s.                                               
2.3.1 Role of B cell
systemic immune response
2.3.1.1 Systemic response to lipopolysaccharide
In order to address the biological relevance of B cell
immune response to LPS, IL
20mg/kg body weight E.coli (O55:B5)
were analyzed for pro-inflammatory cytokine and chemokine
cytokine profile is shown in figure 2.18 
cytokine and chemokine levels. In contrast, the IL
animals, showed no deregulation as indicated by little or no increase in cytokine and chemokine 
levels. The IL-10-/- mice showed high mortality and 
2.18 (B) and (C), respectively. 
restraining the LPS-induced innate 
2.3.1.2 Systemic response to C
B cell-specific IL-10 mutants 
oligodeoxynucleotide challenge. The animals were 
post-challenge the animals were euthanized and serum samples
inflammatory cytokine and chemokine
levels of cytokines and chemokines following challenge. On the contrary, the B cell
mutants behaved like the Cre
derived IL-10 is dispensable for limiting the CpG
2.3.1.3 Systemic response to Poly (I:C)
As B cells express TLR3 and 
IL-10 was described in the murine cytomegalo virus
2009), we expected that B cell
after poly(I:C) challenge. Poly I:C is a 
viral infection. We challenged the B cell
(I:C). 6h post-challenge, serum samples were analyze
-derived IL-10 in counter- regulation
 to TLR ligands  
 
-derived IL-10 in restraining 
-10FL/FL CD19-Cre+ and control animals were i
 LPS and serum samples obtained 6h following challenge 
 levels by luminex bead array.
(A). As expected, the IL-10-/- mice showed enhanced 
-10FL/FL CD19-Cre+ 
high endo-toxicity score as shown in figure 
Thus, our data show no distinct role for B cell
immune response.  
pG oligodeoxy nucleotides
were analyzed for immune deregulation upon CpG 
injected i.v. with 4µg/g body weight CpG. 5h 
 were analyze
 levels. As expected, the IL-10-/- mice showed elevated 
-negative littermate controls. Our results demonstrate that B cell
-induced innate immune response
 
since a non-redundant counter-regulatory role 
 (MCMV) infection model (Madan et al., 
-derived IL-10 might play a role in restraining immune activation 
 synthetic analog of double-stranded RNA
-specific IL-10 mutants i.v. with 15µg/g body weight poly
d for pro-inflammatory cytokine and 
 
, of the 
the systemic 
njected i.p. with 
 The 
mice, like the control 






for B cell-derived 
, which mimics 
 
 
        
Figure 2.18 Role of B cell- derived
(A) Systemic response to LPS. WT (n=2), IL
(n=4), IL-10FL/FL CD19-Cre+ (n=4). LPS E.coli 
and serum samples obtained 6h post
chemokine levels by luminex bead array. 
discharge, diarrhea and lethargy). Due to early mortality in the IL
available only for 6h post-challenge measurement. Error bars represent mean±SD. 
10FL/FL Cre- (n=15),  IL-10-/- saline injected (n=4), 
 IL-10 in restraining the LPS-induced innate 
-10FL/FL Cre- (n=5), IL-10-/- saline control (n=1), IL
(O55:B5) 20mg/kg body weight or saline was injected i.p. 
-challenge were analyzed for pro-inflammatory cytokine and 
(B) Survival (C) Endo-toxicity score (pilo
-10-/- mice the endo






-toxicity scores were 
WT (n=7), IL-
-Cre+ (n=14). 
         
Figure 2.19 Role of B cell- derived
(A) Systemic response to CpG oligodeoxynucleotides. WT (n=2), IL
Cre+ saline control (n=1), IL-10-
body weight CpG oligodeoxynucleotides or saline
analyzed for pro-inflammatory cytokine and chemokine lev
Endo-toxicity score (pilo-erection, ocular discharge, diarrhea and lethargy). Error bars represent 
mean±SD. Due to early mortality in the IL
and 12h post-challenge measurements.
saline injected (n=1), IL-10-/- (n=4), 
 IL-10 in restraining the CpG-induced innate 
-10FL/FL Cre
/- (n=4), IL-10FL/FL CD19-Cre+ (n=4). Mice were injected i.v. with 4µg/g 
 and serum samples obtained 5h post
els by luminex bead array. 
-10-/- mice the endo-toxicity scores were available only for the 5h 
 WT (n=2), IL-10 FL/FL Cre- (n=4), 
IL-10 FL/FL CD19 Cre+ (n=4) 
 
 
immune response  
- (n=4), IL-10FL/FL CD19-
-challenge were 
(B) Survival (C) 
IL-10FL/FL CD19 Cre+ 
  
Figure 2.20 Response of B cell
(A) Systemic response to Poly (I:C). WT (n=2), IL
(n=3), IL-10FL/FL CD19-Cre+ (n=4). Mice were injected i.v. with 15µg/g 
serum samples obtained 6h post
levels by luminex bead array. 
diarrhea and lethargy). Error bars represent mean±SD.
saline control (n=1), IL-10-/- (n=2), 
-specific IL- 10 mutant mice to Poly (I:C) administration
-10FL/FL Cre- (n=5), IL-10-/- saline control (n=1), IL
 body weight poly (I:C) or saline and 
-challenge were analyzed for pro-inflammatory cytokine and chemokine 
(B) Survival (C) Endo-toxicity score (pilo-erection, ocular discharge, 
 WT (n=2), IL-10FL/FL





 Cre- (n=5), IL-10-/- 
chemokine levels. We found there was a tendency 
10-/- mice with high endo-toxicity score. However, 
10FL/FL CD19-Cre+ mice (like Cre
derived IL-10 is dispensable in the regulation of the TLR3 response.
2.3.2 Role of mast cell
responses to CpG oligonucleotides
Using the experimental procedure described in figure 2.21
mice were analyzed for their local immune response
repetitive injections of CpG DNA
inflammatory infiltration, presence or absence of neutrophils
acanthosis (epidermal thickening
of 6 IL-10FL/FL Mcpt5-Cre+, 5 m
infiltration, necrosis and acanthosis hyperkeratinosis, like wild type controls (n=7). One of the 6 
mice showed intense epidermal thickening which may be due to changes unrelated to the CpG 
injection (injury due to fighting
substantial infiltration, necrosis, e
to error in genotyping, which will be clarified in the near future. 
expected, showed massive infiltration 
hyperkeratosis whereas the control IL
showed only moderate infiltration and edema w
acanthosis hyperkeratosis. This data suggested that IL
regulating the local innate immune response to 
                     
Figure 2.21 Scheme for repetitive s.c
CpG oligonucleotide (2.5 µg in 50 µL NaCl) was injected daily at the same site (flank) for 5 days. Tissue 
was sampled on day 6, and paraffin sections were stained with H&E
for increased IL-6 and MCP
no immune deregulation
- negative littermate controls). Our data suggest
 
-derived IL- 10 in regulating local immune 
 
, the mast cell
 to CpG oligonucleotides
. The animals were histologically scored for 
, necrosis, 
) and hyperkeratosis (thickening of the stratnum corneum). 
ice showed moderate infiltration and edema with no neutrophil 
, or faulty injection). One IL-10FL/FL Mcpt5
dema and acanthosis hyperkeratosis. This 
All 
with neutrophils, edema, necr
-10-/- mice (n=2) (injected with mock CpG oligonucleotides) 
ith no neutrophil infiltration, necr
-10 from mast cells is not 
CpG DNA. 
 
. injection of CpG oligodeoxynucleotides. 
 
 
-1 secretion in IL-
 was seen in the IL-
 that B cell-
-specific IL-10 mutant 
 at the site of 
the intensity of 
edema as well as 
Out 
-Cre+ mice showed 
outlier may be due 
IL-10-/- mice (n=4) as 





   












Figure 2.22 Role of mast-cell- derived and DC
to CpG oligodeoxynucleotides
The inflammatory infiltrate is marked by vertical arrows below the panniculus carnosus (muscle layer of 
murine skin). (A) WT mice show
neutrophilic granulocytes. (B) IL
numerous neutrophilic granulocytes, necrosis of epithelial structures and acantho
red intense staining of the epithelium indicates tissue death 
and DC-specific IL-10 mutant mice (IL
moderate infiltration of inflam
granulocytes. (E) IL-10-/- mice treated with mock CpG 




-derived IL-10 in limiting the local immune response
 
 moderate infiltration of inflammatory cells. The infiltrate is devoid of 
-10-/- mice display an intense infiltration of inflammatory cells with 
(C and D)  Mast cell
-10FL/FL CD11c-Cre+) show a response similar to WT mice with 
matory cells, without tissue necrosis or infiltration of neutrophilic 
oligodeoxynucleotides display
Right and left panel (10x and
 
    
 
sis hyperkeratosis. The 
- (IL-10FL/FL Mcpt5-Cre+) 
 mild infiltration with 
 40x magnification, 
     
Table 2.7 Responses of mast cell
IL-10FL/FL Mcpt5-Cre+ and IL-10FL/FL 
shown in figure 2.21 and paraffin sections stained by H & E were scored for 
infiltration, neutrophils, necrosis, edema and acanthosis hyperkeratosis. (
‘moderate’; (+++) ‘severe’; (++++) ‘very severe’ and (+++++) ‘extremely severe’ immune deregulation.
2.3.3 Role of DC
response to CpG DNA
Using the experimental proced
mice were analyzed for their local immune response
injections of CpG DNA. The animals were his
infiltration, presence or absence of neut
(epidermal thickening) and hyperkeratosis (thickening of the stratnum corneum). 
10FL/FL CD11c-Cre+, 5 mice showed moderate infiltration and edema with no neutrophil 
infiltration, necrosis and a mil
(n=7). One CD11c-Cre+ mice showed 
hyperkeratosis. This outlier may be
future.  All IL-10-/- mice (n=4) 
necrosis and acanthosis hyperkeratosis whereas 
mock CpG oligonucleotides) showed 
infiltration, necrosis and acanthosis hyperkerat
-specific and DC-specific IL- 10 mutant mice to CpG DNA
CD11c-Cre+ mice were challenged with CpG oligodeoxynucleotides as 
the intensity of 
-) denotes ‘no’; (+)
-derived IL-10 in the regulation of the 
 
ure as described in figure 2.21, the DC
 to CpG DNA at the site of repetitive 
tologically scored for the intensity of inflammatory
rophils, necrosis, edema as well as acanthosis 
d to absence of acanthosis hyperkeratosis like wild type controls 
substantial infiltration, necrosis, ed
 due to error in genotyping, which will be clarified in the near
as expected, showed massive infiltration with
the control IL-10-/- mice (n=2) (injected with 
only moderate infiltration and edema with no neutrophil 





 ‘mild’; (++) 
 
-specific IL-10 mutant 
 
Out of 6 IL-
ema and acanthosis 
 
 neutrophils, edema, 
-10 from  
dendritic cells is not relevant for regulating the local 
  
Table 2.8 Summary of innate immune responses in various cell
(A) Systemic immune responses to different TLR ligands in IL
mutants (-) “no” (+) “moderate” (++) “severe” deregulation; 
(B) Local immune response to CpG oligodeoxynucleotides in various conditional IL
(+++) “severe” deregulation. 
2.4 Role of IL-10 from different cellular sources
T cell responses 
2.4.1 Relevance of B cell
hypersensitivity response
It has been shown earlier that IL
the cutaneous immune responses 
specific IL-10 mutants (Roers et al., 2004) revealed 
 
innate immune response to 
-type specific IL
-10-/- mice and in B cell
 
-derived IL-10 for regulating the 
 to contact allergens 
-10-/- mice suffer from deregulated contact hypersensitivity 
to contact allergens (Berg et al., 1995). Experiments in T cel
a non-redundant role for T cell
 
CpG DNA.  
                         
-10 mutants 
-specific IL-10 
-10 mutants. (-) “no”; 




- derived  
IL-10 in limiting the CHS response. 
enhanced ear inflammation upon allergen challenge (Watanabe et al., 2007) demonstrating a 
role for B cells in controlling CHS
University, suggest a role for B cell
responses. A unique subset of B cells termed as ‘‘B10’’
mediating the immunosuppression via IL
2008). The authors have performed
from wild type and IL-10-/- mice were
wild type B10 cells suppressed CHS
         
Figure 2.23 Oxazolone- induced contact allergy in B cell
(A) Scheme for oxazolone-induced CHS. Mice were sensitized on the shaved abdomen with 100mg/ml 
oxazolone at day 0 and 1. At day 5, the mice were challenged with 10mg/ml oxazolone on the dor
ventral surface of the ears. Following challenge, ear thickness was measured at indicated time points. 
Percent increase in ear thickness is displayed at indicated time points following challenge. Percent 
increase in ear thickness was calculated
different time intervals after allergen painting. 
IL-10-/- (n=11), IL-10FL/FL CD19
to calculate the significance. **p=0.001
Other studies have shown that also
. Recent findings from the laboratory of Thomas Tedder, Duke 
-derived IL-10 in suppressing T cell-medi
 cells were shown to be involved in 
-10 production (Yanaba et al., 2008, Bouaziz et al., 
 adoptive transfer experiments wherein the B10 subsets 
 transferred to allergen sensitized CD19
 while B10 cells from complete IL-10-/-
            
-specific IL- 10 mutants
 by subtracting the baseline ear thickness from 
WT (n=4), IL-10FL/FL Cre- (n=11), 
-Cre+ (n=13). Error bars represent mean±SD. Student t
-0.01. 
 
 CD19-/- mice display 
ated inflammatory 
-/- mice. Transfer of 





the thickness at 
IL-10-/- vehicle (n=2), 
-test was used 
In order to reproduce this finding in an independent model,
out mice and performed the CHS experiment exactl
for the CHS is explained in figure 2.23
inflammation (Berg et al., 1995) serving as the positive control. Surprisingly, the IL
Cre+ mice and their IL-10-proficient counterparts showed no deregulation suggesting 
derived IL-10 has no essential role
                        
Figure 2.24 DNFB-induced contact allergy in B 
(A) Scheme for DNFB-induced CHS. Mice were sensitized on the shaved abdomen with 0.5% DNFB at 
day 0. At day 5, the mice were challenged with 0.2% DNFB on the dorsal and ventral surface of the ears. 
Following challenge, ear thickness was meas
thickness is displayed at indicated time points following challenge. Percent increase in ear thickness was 
calculated by subtracting the baseline ear thickness from 
allergen painting. WT (n=6), 
10FL/FL CD19-Cre+ (n=10). Error bars represent mean±SD. Student t
significance. *p=0.01-0.05. 
In order to address whether this 
we tested the CHS response to 
challenged using a standard protocol.
 we used B cell
y as described in Yanaba et al.
 (A). As expected, the IL-10-/- mice showed excessive ear 
 in counter-regulation of the CHS response
cell-specific IL-10 mutants 
ured at indicated time points. (B) 
the thickness at different time 
IL-10FL/FL Cre- (n=10), IL-10-/- vehicle (n=4), 
-test was used to calculate the 
result was due to specific properties of the allergen oxazolone
another allergen, DNFB. The animals were sensitized and 
 The scheme for CHS is shown in the figure 2.24
 
-specific IL-10 knock-









 (A). In  
line with the oxazolone-induced CHS results, DNFB
for B cell-derived IL-10 in restraining 
To further validate our findings, 
(Larson et al., 2007). The scheme for the
the previous results, we saw no deregulation of the CHS response in the B cell
in comparison to the controls, while 
response.  
                 
Figure 2.25 Induction of contact allergy in B 
administration of DNFB 
(A) Scheme for DNFB-induced CHS. Mice were sensitized on the dorsal surface of the ears with 0.15% 
DNFB consecutively for three days (days 0
since the T cell-mediated skin inflammation intiates about 48h after primary 
subsequent ear swelling subsided to 
of the ears with 0.15% DNFB (day 22). The increase in ear thickness was measured at indicated time 
points before (day 0, 3 and 5) and after challenge (day 23, 24 and 26). 
thickness is displayed at indicated time points before (day 0, 3 and 5) and after (day 23,24 and 26) 
challenge. Percent increase in ear thickness was calculated by subtracting the b
from the thickness at different time intervals after allergen painting.  
vehicle (n=2), IL-10-/- (n=10), 
test was used to calculate the significance.
-induced contact allergy 
the CHS response.  
we used a different protocol to assess the CHS response
 CHS is explained in figure 2.25 
IL-10-/- mice, as expected, showed a clearly enhanced 
cell-specific IL-10 mutants by repetitive 
-2). The third application can be regarded as a challenge, 
DNFB exposure
baseline levels, the mice were re-challenged on the dorsal surface 
    (B)
IL-10FL/FL
IL-10FL/FL CD19-Cre+ (n=9). Error bars represent mean±SD. Student t
 *p=0.01-0.05. **p=0.001-0.01. ***p <0.001.
 
did not reveal a role 
 
(A). In agreement with 
-specific mutants 
 
. After the 
 Percent increase in ear 
aseline ear thickness 
 Cre- (n=11), IL-10-/- 
-
 
2.4.2 Role of mast cell
hypersensitivity response
Mast cells are reported to be critical regulators in allergy and anaphylactic reactions (Galli et al., 
2005). Mast cells mediators such as TNF (McLachlan et al., 2003), histamine (Jutel et al., 
2001), IL-10 (Grimbaldeston et al., 2007) are implicated in regulating vario
responses.  Grimbaldeston et al.
DNFB- and urushiol-induced contact allergy. 
enhanced CHS, which could be suppressed to normal levels 
  
Figure 2.26 DNFB- induced contact allergy in mast 
(A) Scheme for DNFB-induced CHS. Mice were sensitized on the shaved abdomen with 0.5% DNFB at 
day 0. At day 5, the mice were challenged with 0.2% DNFB on the dorsal and ventral surface of the ears. 
Following challenge, ear thickness was measured at
thickness is displayed at indicated time points following challenge. Percent increase in ear thickness was 
calculated by subtracting the baseline ear thickness from
allergen painting. WT (n=3), 
Mcpt5-Cre+ (n=5). Error bars represent mean±SD. Student t
*p=0.01-0.05. 
-derived IL- 10 in the regulation of delayed 
 to contact allergens 
 reported a critical role for mast cell-derived IL
Mast cell-deficient kit mutant lines displayed 
by reconstitution of these mice with
cell-specific IL- 10 mutants
 indicated time points. (B) 
 the thickness at different time intervals after 
IL-10FL/FL Cre- (n=15), IL-10-/- vehicle (n=1), IL




-10 in limiting 
                   
 
 
Percent increase in ear 
-10-/- (n=8), IL-10FL/FL 
 
‘‘in vitro’’ differentiated mast cells. Importantly, when the reconstituting mast cells originated 
from IL-10-/- mice, CHS was not suppressed. 
model, we generated mast cell
et al., 2004) with the Mcpt5-Cre
Following the experimental protocol of
10FL/FL Mcpt5-Cre+ and Cre-negative control 
shown in figure 2.26 (A). In order to address the relevance of mast cell
late phase of the ear swelling response we
after allergen challenge. As expected, the IL
On the contrary, the mast cell
competent counterparts showed no deregulation of 
response like Cre-negative littermate controls). This data shows 
dispensable for limiting the DNFB
2.4.3 Role of DC- derived IL
hypersensitivity response
Dendritic cells are the main antigen presenting cells and inducers of adaptive immune 
responses. However, also regulatory (immunosuppressive) functions were attributed to these 
cells. Recent studies have shown potential role for langerhans cells (LC) (Bobr et al., 2010) and 
dendritic cells (DCs) (Fukunaga et al., 2008) in modulating the T cell dependent inflammatory 
responses. Also, it has been shown that dendritic cells lentivirally engineered to overexpr
10 inhibit CHS responses (Besche et al., 2010). 
is important in limiting DNFB-induced
In order to validate these findings 
mutant mice and performed the CHS experiment using a standard protocol. The scheme
CHS is shown in figure 2.27 (A).
the IL-10-/- mice (positive control 
al., 1995), showed excessive inflammation marked by a significant increase in ear thickness and 
delayed resolution. In contrast, the Cre
 
In order to reproduce this finding in
-specific knock-out mice by breeding the IL
 line (Scholten et al., 2008) and the litter were analyzed for 
 Grimbaldeston et al. we sensitized and challenged the 
mice with DNFB. The scheme
-derived
 monitored ear thickness for six subsequent da
-10-/- mice showed enhanced ear 
-specific mutants (IL-10FL/FL Mcpt5-Cre
the immune respons
that mast cell
-induced CHS response (Dudeck et al., 2011).  
-10 in the regulation of delayed 
 to contact allergens 
Igyarto et al., have shown that LC
 contact hypersensitivity response.  
in an independent model, we generated DC
 As shown in the figure 2.27 (B), DC-specific IL
with well documented deregulation of contact allergy, Berg et 
-negative littermate controls showed 
 
 an independent 
-10 floxed line (Roers 
CHS. 
IL-
 for CHS assay is 
 IL-10 also in the 
ys 
skin inflammation. 
+), like their IL-10 
e (ear swelling 







-10 mutants like 
only moderate ear  
                            
Figure 2.27 DNFB- induced contact allergy in DC
(A) Scheme for DNFB-induced CHS. Mice were sensitized on the shaved abdomen with 0.5% DNFB at 
day 0. At day 5, the mice were challenged with 0.2% DNFB on the dorsal and ventral surface of the ears. 
Following challenge, ear thickness was measured at indicated time points.
thickness is displayed at indicated time points following challenge. Percent increase in ear thickness was 
calculated by subtracting the baseline ear thickness 
allergen painting.  IL-10FL/FL Cre
(n=16). Error bars represent mean±SD. Student t
10FL/FL CD11c-Cre+ and IL-10FL/FL
 
                
Table 2.9 Summary of deregulated T cell
 IL-10 mutants 
 
Various conditional IL-10 mutant mice were sensitized and challenged with 
phenotype was compared with IL
deregulation. 
 cell-specific IL-10 mutants  
 (B) 
from the thickness at different time intervals after 
- (n=13), IL-10-/- vehicle (n=1), IL-10-/- (n=8), 
-test was used to calculate the significance
 Cre-negative control groups. *p=0.01-0.05. 
-mediated immune responses in various conditional
contact 
-10-/- mice. (-) denotes “No” and (+++) denotes ‘‘severe
 
 





allergens and their 
” immune 
swelling, which rapidly resolved. 
IL-10 in restraining the delayed 
2.5 Role of IL- 10 
intestinal immune homeostasis 
IBD is a general term referring to inflammatory digestive tract conditions. 
manifesting as IBD are Crohn’s disease (CD) and ulcerative co
spontaneously develop intestinal inflammation resulting from an unbalanced Th1 response to 
luminal bacterial antigens, which demonstrate the essential role of IL
homeostasis (Kuhn et al., 1993). 
the mice are exposed to and does occur in germ free mice. The cellular sources
relevant in controlling IBD are 
et al., 2004) revealed T cells as an important source of IL
experiments from other investigators have shown natural T regulatory cells (Treg) as a potential 
cell type mediating immunosuppression via IL
2008).  
In order to investigate whether IL
regulation, we investigated the B cell
2.5.1 Relevance of B cell
B cells are a prominent source of IL
expression of CD1d and CD5
immune responses in various disease 
cells characterized by high CD1d expression confers protection against intestinal inflammation 
via IL-10 secretion. Recently it was shown that subset of CD1d
cells) have an essential role in protection from gut 
In order to reproduce this finding in an independent model, B cell
housed in Cologne animal facility to spontaneously develop IBD. As an indicator o
the animals develop rectal prolapse. The complete IL
10FL/FL CD4-Cre+) showed macroscopic evidence for IBD developing rectal prolapse. Complying 
This result demonstrates an indispensable role for DC
type hypersensitivity response. 
from different cell types 
 
litis (UC). IL
-10 in intestinal immune 
IBD in IL-10 deficient mice is dependent on the bacterial milieu 
not clear. Earlier experiments in IL-10FL/FL CD4
-10 in limiting gut inflammation. Further 
-10 and TGF-β (Uhlig et al., 2009
-10 from other cellular sources has a role in 
- and DC-specific IL-10 mutant mice. 
-derived IL-10 in regu lating gut inflammation
-10 upon various stimuli. Regulatory B cells characterized by 
 were reported to restrain inflammation and negatively regulate 
conditions. Mizoguchi et al. reported that a subset of B 
hiCD5+ regulatory B cells 
inflammation (Yanaba et al.,
-specific IL




Two human diseases 
-10-/- mice 
 of the cytokine 
-Cre+ mice (Roers 





-10 mutants were 




with the macroscopic observation, histological section of colonic samples showed massive 
infiltration of inflammatory cells. In contrast, the B cell
showed no signs of IBD. As the outcome of the disease depends on the hy
animal facility, we housed our B cell
rapidly develop IBD and assessed
analysis of intestines from B cell
Furthermore, the IL-10FL/FL CD19
(Werner Muller; Manchester, personal communicatio
cell-derived IL-10 is dispensable for
     
Figure 2.28 Incidence of colitis in B cell
IL-10-/- (n=29); IL-10FL/FL CD4
animal facility and the frequency of rectal prolapse among the groups were analyzed for the indicated 
time points. Prolapse of the rectal mucosa is a typical sign of severe colitis in mice. Incidence of rectal 
prolapse among different experimental groups is displayed as percent of mice displaying 
2.5.2 Relevance of DC
DC are professional antigen presenting cells localized in the epidermis, mucosal epithelia and 
the interstitial connective tissue of nonlymph
internalize antigens, process them and initiate adaptive immune responses by activating 
antigen-specific T cells. We hypothesized that DC
 
-specific mutants (IL
-specific IL-10 mutants in a facility in 
 the colonic samples for inflammatory 
-specific IL-10 mutant mice never revealed any signs of IBD. 
-Cre+ mice failed to develop IBD in an inducible model for colitis 
n). These results clearly indicate
 regulating gut inflammation. 
-specific IL-10 mutants 
-Cre+ (n=49);  IL-10FL/FL CD19-Cre+ (n=56) were housed in 
-derived IL- 10 in regulating gut inflammation
oid tissues (Kubach et al., 2005
-derived IL-10 could be involved in intestinal 
 
-10FL/FL CD19-Cre+) 
giene status of the 
which IL-10-/- mice 
changes. Histological 





). These cells 
 
immune homeostasis. In order to answer this question, we housed the DC
mice (IL-10FL/FL CD11c-Cre
Unfortunately, we did not observe any macroscopic signs for IBD in these animals. Also, only a 
few fraction of complete IL-10 ko mice (IL
Therefore, we were not able to address the role of DC
           
Table 2.10 Summary of occurrence of intestinal infl ammation in conditional IL
IL-10-/- mice and various cell type
animal house and analyzed for intestinal immune deregulation. Rectal prolapse and microscopic analysis 
of the colonic samples were used to assess the incidence of colitis amo












+) and Cre-negative littermate control in our 
-10-/-) developed rectal prolapse under these settings. 
- derived IL-10 in IBD. 
-specific IL-10 mutants were housed in the Cologne and MTZ, Dresden
ng various conditional mutants. (
”; ND- “not determined”; UI-“under investigation”.
 









IL-10 is a potent anti-inflammatory cytokine secreted by variety of hematopoietic and non
hematopoietic cell types. Complete loss of 
immune responses. Evidence
shown distinct and non-redundant functions for IL
focuses on the in vivo relevance of IL
various immune responses. Studies from other labs addressing the functions of IL
these cell types were based on adoptive transfer experiments. 
limitations and therefore an 
relevance of IL-10 from these cell types
 The experiments of this thesis were based on the selective 
mast cells and DCs using the 
type specificity of Cre-mediated recombinati
single cell PCR. The conditional mutants were challenged with different stimuli (like TLR
and haptens/allergens). Furthermore
an overview of IL-10 expressing cells 
correlated with the phenotypes 
3.1 IL-10 reporter 
inflammatory responses
Detection of cells actively producing a particular cytokine by means of immunostaining is 
challenging due to problems of sensitivity and specificity. Transcriptional cytokine reporter mi
represent an attractive alternative approach. In such mice, a fluorescent reporter protein is 
expressed under the control of the cytokine promoter and reporter fluorescence can be detected 
by flow cytometry in cell suspensions obtained e.g. by tissue di
tiger mice (Kamanaka et al., 2006)
shown to faithfully report IL-
various inflammatory conditions such as endotoxemia, murine cytomegaloviral (MCMV) 
 
IL-10 function results in inappropriately vigorous 
 from the literature and earlier reports from our laboratory have 
-10 from individual cell types
-10 from B cells, mast cells or DCs in the regulation of 
This approach has inherent 
independent model is necessary to determine 
 in immune regulation. 
inactivation of 
Cre/LoxP recombination system. The deletion efficiency 
on was demonstrated by Southern 
, insights from IL-10 transcriptional reporter mice gave us 
in the various immune responses. 
of the conditional IL-10 mutants.  
activity in different cell types 
 
gest. Unlike the earlier reported 
, the Vert-X transcriptional IL-10 reporter mouse, had been 
10 transcription (Madan et al., 2009) with high sensitivity under 
 
-
. This thesis 
-10 from 
the biological 
il10 gene in B cells, 
and cell 
blot analysis and 
 ligands 




infection and challenge with foreign antibodies to IgD. 
mice for detecting the in vivo 
induced contact hypersensitivity response (CHS).
3.1.1 CD1dhiCD5+ B cells are promie
LPS challenge 
Regulatory B cells were described
conditions such as chronic colitis (Mizoguchi et al., 2006), collagen
(Mauri et al., 2003, Carter et al., 2011), type 1 diabetes (Hussain et al., 2007), contact 
hypersensitivity (CHS) (Yanaba et al., 2008) and experimental autoimmune encephalomyelitis 
(EAE) (Fillatreau et al., 2002, Matsushita et al., 2008). These cells were reported to 
suppressive functions via secretion of IL
The IL-10 producing capacity was tested 
LPS, PMA, ionomycin and monensin
immunofluorescence staining. (Yanaba et al., 2008). 
analysis confirmed that CD1d
We were able to recapitulate this finding in 
systemic stimulation with LPS. We observe
cells while only 3.4% of conventional B cells
B10 regulatory cells display a particular propensity to produce 
3.1.2 Lack of IL- 10 production in splenic B cells after allergen 
challenge of the skin  
As detailed above, Yanaba et al. described B10 
manner. Surprisingly, they found induction of B10 cell IL
the challenged ear skin, namely in the spleen. In contrast to the splenic B10 cell subset, 
conventional splenic B cells did not switch on IL
FACS-sorting of splenic B cells 
to quantify IL-10 transcript levels. This observation was i
restrain ear skin inflammation.  However, when we sensitized and challenged the
transcriptional reporter mice and analyzed splenic B cells for IL
Therefore, we utilized the Vert
IL-10 producing cells, during systemic LPS challenge and 
 
nt producers of IL
 to negatively regulate immune responses in various disease 
-induced arthritis (CIA) 
-10. Hence these cells were designat
in vitro, by stimulating splenic cells with 
 for 5h and assessed for IL
These experiments and Affymetrix
hiCD5+ cells were major producers of IL-10 upon LPS challenge. 
Vert-X IL-10 transcriptional reporter mice
d 17.7% reporter positive cells among 
 expressed the reporter. Hence, our data 
IL-10 upon 
cells to control CHS in an IL
-10 transcription at a site distant
-10 transcription. This finding was based on 
from vehicle and oxazolone challenged mice and real time PCR 
n support with the finding that B10 




-10 upon in vivo 
exert their 
ed as ‘‘B10’’ cells. 
a cocktail of 









 Vert-X IL-10 
 
upregulation of reporter expression 
finding clearly is at conflict with the study of Yana
being insensitive to detect GFP
10 induction in B10 cells upon LPS challenge. Also, the system showed robust
expression in allergen challenged ears where even few green cells can be det
FACS. Furthermore, in a model of asthma these mice elicited strong reporter expression from 
various cell types (Thilo Jakob
immunotherapy (SIT). Therefore, our data suggests a lack of IL
regulatory cells after oxazolone challenge.
3.1.3 Lack of reporter expression in ear skin B cells, ma st cells and 
NK cells during the elicitation phase of CHS
B cells with immune regulatory functions have been described in the literature. 
mice and mice with compromised BCR signaling (
Adoptive transfer of splenic B cells from sensitized wild type mice to Cd19
reported to reduce CHS to normal levels 
al., 2007). In line with these findings,
were shown to actively suppress the excessive inflamma
(Yanaba et al., 2008). Earlier studies have documented that IL
(within the inflammatory lesion) mediate immune suppression during leishmania and 
toxoplasma infections (Anderson et al
numbers and their IL-10 reporter activity in ear skin samples 
results indicated that B cell numbers moderately increased in 
challenge. We did not detect reporter expression in B cells at any of the 
challenge. This data suggests 
the excessive ear inflammation. 
production could be induced in B cells of skin draining lymph nodes after skin challenge with 
contact allergens.  
Another cell-type that is important 
immunostimulatory functions, mast cells 
responses by secreting IL-10 (Galli et al., 2008). An important finding in this 
in B10 cells from control or allergen treated 
ba et al. The possibility of the reporter system 
+ cells is unlikely as the same system readily detected 
, Freiberg, personal communication) before and after specific




suggesting a regulatory role for B cells (Watanabe et 
 B10 cells characterized by CD1d and CD5 expression 
tion of CD19-/- mice 
-10 from a particular cell source 
., 2007; Jankovic et al., 2007). W
following allergen challenge. O
allergen treated
time point after allergen 
that IL-10 from B cells in the ear tissue is not relevant
However, our data do not exclude the possibility that IL
in the context of contact allergy is the mast cell.





ected precisely by 
 
B cell-deficient 
 augmented CHS. 
-/- recipients was 
by IL-10 production 
e analyzed B cell 
ur 
 ears at 120h post-
 for limiting 
-10 
 In addition to 
line was the role for  
mast cell-derived IL-10 in regulating contact hypersensitivity
exposed to urushiol and DNFB, the 
ear swelling. When conventional mast cell
engrafted with bone marrow-derived mast cells of wild type 
wild type cells suppressed CHS. 
IL-10. However, our experiments in IL
skin mast cells at any time point after allergen challenge. This finding is at conflict with the study 
of Grimbaldeston et al. However, it is in accordance with our finding that CHS is not deregulated 
in mast cell-specific IL-10 mutant mice.
Also, NK cells are capable of producing IL
dependent immune response, the contribution of NK cells in the developme
inflammatory response to contact allergens
2006). It was shown earlier in 
invade the ear lesion as early as 2h after challenge
and IFN-γ in challenged ear skin
regulating the CHS response is yet u
have an adaptive memory-like effect i
cells is also suggested. We o
ears while, NK cells appeared 
effects has been reported in mouse cytomegalo viral infection (MCMV) and a regulatory role for 
IL-10 from NK-cells has been suggested in tumor development, chronic hepatitis C infection and 
pregnancy (reviewed in Hedrich et al., 2010) we wondered whether the NK 
contributes to the regulation of the CHS response. 
reporter expression in these cells 24
GFP fluorescence at all time points after challenge




 (Grimbaldeston et al., 2007). When 
kit mutant mast-cell deficient mouse lines show
-deficient mouse lines kitW/W-v and
or IL-10-/- mice,  
This result suggested suppression of CHS by mast cell
-10 reporter mice did not reveal reporter expr
 
-10 (Vigano et al., 2001). Though CHS is a T cell
 are currently being addressed
oxazolone-induced CHS, that NK cells are the first cell 
. These cells predominantly produce IL
 (Kaneko et al., 2003). The relative contribution of NK cells in 
nclear. O’Leary et al. suggested that 
n CHS. In addition, an allergen-specific property of NK 
bserved an almost complete absence of NK cells in the control 
in challenged ears. As NK cell-derived IL-10 with host protective 
Therefore, we assessed
-120h after hapten application but could detect no reporter 




        kitW-sh/W-sh  were 
only the transfer of 
-derived 
ession in ear 
- 
nt of the 
 (O’ Leary et al., 
type to 
-2 
the NK cells seem to 
cell-derived IL-10 
 Vert-X IL-10 
-
3.1.4 IL-10 reporter expression in CD4 T cells and DC 
challenged ear tissue  
The delayed hypersensitivity response 
response with participation of both CD4 and CD8 T cells. 
important effectors of CHS, CD4 T cells were also described to exert regulatory functions in 
CHS (Vocanson et al., 2009). Several studies from the past 
involvement of T cells (Krasteva et al., 1999;
IL-10 (Berg et al., 1995) in down
allergens. Further steps in this direction, have shown an indispensable role for T cell
10 in mediating the suppressive effects as 
CHS response (Roers et al., 2004; reviewed in Roers
the IL-10 secreted from T regulatory cells is 
reporter expression, we report here that CD4 cells 
efferent phase of CHS. Comparison of 
baseline reporter expression in 
percentage of IL-10 expressing CD4 T cells 
question is whether the IL-10 expressing CD4 T cells in untreated or allergen
represent regulatory T cells. This
staining for FoxP3 or by crossing the Vert
Another cell type capable of producing IL
significant increase in DC numbers at most of the time points 
reporter expression was detected only in a small fraction of ear skin DCs 
unchallenged ears. A clear role
from the available literature one could possibly speculate their effects in imparting a tolerogenic 
phenotype. This phenomenon has been tested 
becomes tolerogenic (Steinbrink et al., 1997). Therefore, IL
autocrine manner down-regulating the 
thereby creating an anergic environment wherein the T cells are no longer activated
inhibiting the downstream processes in the inflammation. Th
derived IL-10 could be involved in inducing the Tr1 cells or other inducible T regulatory cells to 
maintain peripheral tolerance as shown earlier by 
to contact allergens is a DC-dependent
While CD8 cells are portrayed as 
ten years have documented the 
 Gorbachev et al., 2001) and also the relevance of 
-regulating the massive inflammatory response to contact 
T cell-specific IL-10 mutant mice 
 et al., 2008). Rubtsov et al. 
important in regulating CHS. 
produce IL-10 in the ear tissue 
control and hapten treated ears revealed 
CD4 T cells in unchallenged ear tissue
increased moderately in ear skin.
 question could be addressed by an additional intracellular 
-X reporter on to a FoxP3 reporter line.
-10 in the inflamed ears are DCs
after allergen challenge. 
in comparison with the 
 for DC-derived IL-10 in regulating CHS 
in vitro where DCs 
-10 from 
expression of MHC and co-stimulatory molecules
e second possibility is that DC
Groux et al. Recently, it was shown by
 
in hapten- 




Based on Vert-X IL-10 
during the 
that there is a 
. Upon challenge, the 
 An interesting 
-challenged skin 
  
. We found a 
IL-10 
is yet unidentified but 
upon IL-10 treatment 





Fukunaga et al.  that dermal 
dispensable for initiating CHS response. However, 
Langerhans cells in regulating CHS responses as LC deficient mice showed enhanced ear 
swelling. Mice selectively deficient for 
CHS responses (Igyarto et al., 2009). As we had least success with LC staining
comment on this cell type here. In summary, our data shows a significant rise in th
numbers and a marginal IL
challenge. This data suggests
Nevertheless, further experiments are needed to directly address the role of 
derived IL-10 in inducing or maintaining 
3.1.5 Prominent IL- 10 reporter expression in ear skin CD8 T cells 
following DNFB challenge
Studies from the past years have in great detail assessed the role of T cells in contact allergy 
demonstrating an effector role for CD8 cells and regulatory role for CD4 cells (Vocanson et al., 
2009). We observed that the CD8 cell numbers 
remained high until 120h post
nearly complete absence of CD8 cells. 
of the skin CD8+ cells with a peak at 
at this time point). This data possibly indicates that t
effector cells which may limit their own proinflammatory functions by IL
autocrine fashion or may control activity of other inflammatory cells. Thus CD8 T cell
10 may be critical in regulating the CHS response. This hypothesis is in accordance with our 
finding that T cell-specific IL-10 mutants show augmented
phenotype of the complete IL
the models of leishmania and 
and IFN-γ) were reported to actively mediate immunosuppression via IL
et al., 2007; Jankovic et al., 2007).
can be important in the control of proinflammatory functions of this same e
refuting the concept that IL-10 mediated suppression is a function of specialized regulatory T 
cell subsets only. However, regulatory functions for IL
the model of graft-versus-host disease (GVHD
DCs are critical for T cell priming while langerhans cells (LC) are 
a study by Kaplan et al. suggests a role for 
il10 gene in Langerhans cells (LC) also showed enhanced 
-10 reporter expression at indicated time points 
 a role for DC-derived IL-10 in regulating CHS responses. 
peripheral tolerance following allergen challenge
 
increased massively after hapten challenge and 
-challenge. On the contrary, the vehicle treated ears showed a 
IL-10 reporter expression was induced in a large fraction 
48h post-challenge (16% of CD8+ skin cells were positive 
he CD8 cells could be allergen
 CHS response clos
-10-/- mice (Roers et al., 2004; reviewed in Roers et al., 2008)
T.gondii, the effector Th1 cells (capable of secreting both IL
-10 secretion 
 These studies demonstrate that IL-10 from effector T cells 
-10-secreting CD8 cells were reported in 
) (Noble et al., 2006). Also, IL
 
 we do not 





-10 production in an 
-derived IL-





-10 secreting CD8  
cells were reported to regulate allergic immunopathology 
(Seneviratne et al., 2002). Further experiments are needed to show whether the IL
CD8 cells constitute a specialized regulatory subset or allergen
3.2 Efficiency and specificity of Cre
the il10 gene in different cell types 
3.2.1 CD19 Cre-mediated deletion is highly efficient in convention al 
and CD1d hi CD5+ B cells
As a first step in identifying distinct roles for B cell
immune stimuli, IL-10FL/FL CD19
loxP-flanked il10 allele. Rickert et al
95% in splenic B cells. We demonstrated the deletion of 
by Southern analysis (Madan et al., 2009). 
ascribed to the subset of CD1d
extent of Cre-mediated deletion in this particular subset. Southern blot analysis of this small 
subpopulation is not possible. 
1-2% among the CD19+B220
PCR amplification of the loxP
PCR results clearly indicated the eff
conventional B cells and B10 regulatory cells
B cells. In order to test the sensitivity of our assay, we sorted few T cells into tubes contain
several B cells. Our single cell PCR method faithfully detected rare undeleted IL
among a majority of deleted alleles. Thus we could use the system to estimate the frequency of 
B10 regulatory cells with intact IL
multiple cells sorted into one tube. 
a total of 250 cells, among which we detected undeleted IL
containing 50 B10 cells). One also
that in rare cases a non-B cell may be sorted instead of a B10 cell. Thus, we estimate the 
efficiency of Cre-mediated deletion in B10 cells to be atleast 99%.  
 
in the model of atopic dermatitis 
-specific effector cells. 
-mediated inactivation of 
 
 
-derived IL-10 in responses to different 
-Cre mice were analyzed for cell type-specific inactivation of the 
. reported a CD19 Cre-mediated deletion efficiency 
the il10 floxed allele
Since IL-10 dependent regulatory functions were 
hiCD5+ B cells (B10 cells), it was important to determine the 
As reported by Yanaba et al. B10 regulatory cells constitute only 
+ double positive B cells. Therefore, we performed 
-flanked IL-10 locus on FACS sorted splenic 
iciency of Cre-mediated deletion to be close to 100% in both 
. We did not detect deletion in cell types other than 
-10 genes in IL-10FL/FL CD19-Cre mice by analyzing samples of 
Thereby the number of B10 cells analyzed was increased to 
-10 alleles only once (in a sample 






 in splenic B cells 
single target 
cells. The single cell 
ing 
-10 alleles 
3.2.2 Cre-mediated deletion is
detected in other cell types in IL
To study the biological relevance of mast cell
inflammatory responses, we bred IL
mediated deletion was demonstrated by 
mast cells from the peritoneal cavity or skin
be close to 100% in both perito
yielded ‘‘deleted’’ PCR products
absence of significant deletion in non
include this experiment in the present thesis. The data available to date are in accordance with 
the cell-type specific and efficient inactivation of the 
Cre mice. Therefore, this system 
derived IL-10. 
3.2.3 Cre-mediated deletion is 
be detected in other cell types in IL
To elucidate the in vivo relevance of DC
responses, we generated DC
Cre line. The efficiency of Cre
FACS-sorted DCs from spleen
be close to 100% in both spleen (in plasmacytoid and conventional DC)
non-DC never yielded ‘‘deleted’’ PCR products
further support the absence of deletion in non
include this experiment in the present thesis. The data available to date are in accordance with 
the cell-type specific and efficient inactivation of the 
mice. Therefore, this system 
adaptive immune responses. 
 
 
 efficient in mast cells and cannot be 
-10FL/FL Mcpt5- Cre mice
-derived IL-10 in cutaneous
-10FL mice with the Mcpt5-Cre line. The efficiency of Cre
single cell PCR on FACS-sorted mast cells and non
. We found the efficiency of Cre
neal lavage and ear skin mast cells, while non
. A Southern blot analysis will be performed to 
-mast cells. For time constraints, it was not possible to 
il10 gene in mast cells of 
can be used to seek insights about the functions of mast 
efficient in dendritic cells and cannot 
-10FL/FL CD11c-Cre mice
-derived IL-10 in innate and ada
-specific IL-10 mutants by crossing IL-10FL 
-mediated deletion was demonstrated by single cell PCR on 
 or ear skin. We found the efficiency of Cre
  and ear skin 
. A Southern blot analysis will be performed to 
-DC. For time constraints, it was not possible to 
il10 gene in DC of 
can be used to study the role of DC-derived IL
 
 
 innate and adaptive 
-
-
-mediated deletion to 






mice with the CD11c-
-mediated deletion to 
DC, while 
IL-10FL/FL CD11c-Cre 
-10 in innate and 
3.3 Innate immune responses in cell type
mutants 
3.3.1 B cell- derived IL
responses 
It has been reported earlier, that mice with complete 
deregulated cutaneous immune responses and increased pro
upon LPS stimulation (Berg et al., 1995). Sel
sensitivity to endotoxic shock (Roers et al., 2004; 
with selective deletion of il10 
LPS (Siewe et al., 2006; reviewed in Roers et al., 2008). 
Christopher Karp, Cincinnati,
positive for eGFP expression upon LPS challenge, 
secreting cell type in the LPS response
moderate deregulation of immune responses 
mice. We therefore, tested the B cell
immune challenge with LPS or other TLR ligands (CpG or Poly (I:C) which
Unexpectedly, inactivation of the 
immune responses to systemic LPS, CpG 
inflammatory cytokine levels, mild clinical scores and high survival 
observations for the wild type littermate control
deficiency showed massive increase in pro
and mortality. In summary, we conclude the immune
responses to LPS, CpG or Poly (I:C)
redundant roles of IL-10 from B cells





-10 is dispensable for the control of TLR 
IL-10 deficiency 
-inflammatory cytokine 
ective deletion of il10 in T cells 
reviewed in Roers et al., 2008), 
in macrophages and neutrophils exhibited enhanced 
The group of our collaborator 
 has demonstrated that about 89% of splenic CD19
indicating that B cells 
. Interestingly, the Karp group have also demonstrated a 
to MCMV infection in the IL
-specific IL-10 mutants for their 
il10 gene in B cells did not result in deregulation 
or Poly(I:C) challenge. The moderate increase in pro
were not different from the 
 group. As expected, the mice with complete 
-inflammatory cytokine levels with high clinical score 
-counter regulation effects in restraining 
 were independent of B cell-derived IL




show high mortality, 
responses 
did not alter 
whereas mice 
sensitivity to 
+ cells were 
are a major IL-10 
-10FL/FL CD19-Cre 
response to systemic 
 mimic viral infection). 




3.3.2 Mast cell- and DC
inflammatory responses to CpG 
Earlier studies have shown that 
administration of CpG demonstrating the relevance of IL
Previous results from our group 
cells and macrophages (Siewe et al., 2006). Here we report, that 
specific IL-10 mutant mice behaved like wild type control animals upon CpG challeng
hypothesize that a compensatory mechanism may operate wherein the absence of IL
cell-type is complemented by IL
source of IL-10 is a cell type other than T cells, macrophages,
non-hematopoietic cell type like keratinocytes or fibroblasts. We will address this question by 
analyzing single cell suspensions from CpG
cellular sources of IL-10 in th
knock out mice by crossing the IL
3.4 Relevance of cell
cell- mediated inflammatory
3.4.1 B cell- derived IL
Several studies have documented a potential role for regulatory T cells both naturally occurring 
CD4+CD25+ (Gorbachev et al., 2010; Murai et al., 2009; Ring et al., 2006) and antigen induced 
regulatory cells in mediating the immune suppression via IL
hypersensitivity. In parallel to this, B cells with regulatory properties have been described in the 
literature. A unique subset of regulatory B cells which shares characteri
cells and have high CD1d and CD5 expression 
Bouaziz et al., 2008). These cells are implicated in immune regulation
and auto-immune diseases such as diabetes (Huss
arthritis (CIA) (Mauri et al., 2003; Carter et al., 2011), contact
al., 2008) and experimental autoimmune encephalomyelitis (EAE) (Fillatreau et al., 2002, 
Matsushita et al., 2008). Experiments
-derived IL-10 is dispensable for the control of 
oligodeoxynucleotides
IL-10-/- mice show excessive inflammation upon sub cutaneous 
-10 in limiting the local CpG responses. 
show that the regulation is independent of IL
also the mast cell
-10 produced from other cell type(s). Alternatively, the relevant 
 mast cells and DC for example a 
-lesions of    Vert-X IL-10 reporter mice to identify 
e tissue. Furthermore, we will generate keratinocyte
-10 flox line to K14-Cre transgenic mice (Dassule
-type derived IL- 10 in the regulation of T 
 responses 
-10 in the control of CHS 
-10 in the model of delayed 
stics
were reported recently (Yanaba et al., 2008; 
 in various inflammatory 
ain et al., 2007), chronic collagen induced 
 hypersensitivity (CHS) (Yanaba et 
 in CD19-/- mice have shown a critical involvement of 
 
 
-10 derived from T 
- and DC-
e. We 
-10 in one 
-specific IL-10 
 et al., 2000). 
 of marginal zone B 
B  
cells in regulation of T cell-mediate
in this direction proved the existence of 
as “B10” cells (CD1dhiCD5+). These cells were described to
effects via copious secretion of IL
2010). In the Vert-X reporter animals, we could reproduce that B10 cells have a particular 
propensity to secrete IL-10. U
of non-B10 B cells were GPF
IL-10 dependent regulatory functions of B10
adoptive transfers of FACS-sorted B10 cells, either wi
responses in the recipients. Adoptive transfer of B10
drastically brought down the abnormal 
B or IL-10-/- B10 cells failed to elicit a protective function (Yanaba et al., 2008). In order to 
address the role of B cell-derived IL
selectively in B cells and analyzed these conditional mutants in the CHS model
and re-exposure to potent haptens such as oxazolone 
et al. Complete loss of the il10
delayed resolution as expected
in B cells did not affect the inflammatory responses
allergen, DNFB, and with various protocols of CHS elicitation 
Our findings are at controversy
explanation for the discrepancy 
competent B cells into CD19-
cells may have difficulties in trafficking to their site of action and function. 
Unexpectedly, Yanaba et al. had found induction of IL
distant to the contact allergen
intracellular immunostaining detected by flow cytometry. We have addressed the question of 
IL-10 induction in splenocytes after skin allergen challenge in the Vert
could not observe reporter expression in conventional or 
our data provide strong evidence that B cell
 
d immune responses (Watanabe et al., 2007). Further efforts 
a specialized population of regulatory B cells designated 
 exert their negative regulatory 
-10 (Yanaba et al., 2008; Bouaziz et al., 2008; DiLillo et al., 
pon systemic LPS immune stimulus 17% of 
+ positive. The pivotal experiment on which the demonstration of 
 cells was based in the published studies was 
ldtype or IL-10-/-, and analysis of immune 
 cells from sensitized mice to CD19
ear inflammation of these mutants. 
-10 in an independent system, we knocked out the 
was performed as 
 gene resulted in increased intensity of 
. In contrast to the complete knock outs, selective
. Similar results were obtained with 
(Larsen et al., 2007)
 with the above cited literature (Yanaba et al., 2008
may be due to artifacts arising from the transfer of CD19 
/- mice with a compromised B cell compartment. The transferred B 
 
-10 expression in B10
-challenged skin, namely the spleen. This experiment relied on 
-X IL
CD1dhiCD5+ B cells. Taken together, 
-derived IL-10 plays no role in the control of CHS. 
 
B10 cells but only 3% 
-/- mice 
In contrast, non-B10 
il10 gene 
. Sensitization 
described by Yanaba 
ear inflammation and 




 cells at a site 
   
-10 reporter mice and 
 
In the model of CHS, the regulation seems to be unaffected by selective deletion of 
cells whereas, in the model of EAE
initiation and progression of the disease. Earlier experiments in the model of EAE have 
demonstrated that B cells are indispensable for regulating the pathogenesis of the disease 
(Fillatreau et al., 2002). The B10
disease (Matsushita et al., 2010). 
tested in the model of EAE 
counter-regulation via IL-10 (
experiments are on the way characterizing the regulatory B cells phenotype involved in the 
disease manifestation. Existence of human regulator
characterized by CD24hiCD27
down-regulating monocyte cytokine secretion via IL
in disease conditions such as 
sclerosis and other autoimmune diseases. Existence of regulatory B cells
Blair et al. who identified regulatory sub
that the regulatory B cells in SLE patients we
10 and displayed no significant difference in their frequencies among SLE patients and healthy 
counterparts (Blair et al., 2010
the exact role of regulatory B cells in steady state and in auto
selective ablation of il10 in B cells in combination with the Vert
ideal tools to better understand the role of B cell
3.4.2 Mice selectively 
CHS responses 
Mast cells are best known for their role in IgE
2002), but have also been reported to have essential functions in immune responses and 
pathogen defense. In addition to the immuno
products, a study described immunosuppressive 
 
 
, it seems, there is a role for B cell
 cells were reported to critically regulate the initial phase of the 
In accordance with these data, IL-10FL/FL
and showed delayed recovery, suggesting a B cell
Ari Waisman, Mainz, personal communication). Detailed 
y B10 cells was re
+ phenotype and seemed to suppress immune responses by 
-10 dependent pathways (Iwata et al., 2011) 
rheumatoid arthritis, systemic lupus erythematosus, multiple 
-sets as CD19+CD24hiCD38hi. However, it was shown 
re refractory to CD40 activation, produced less IL
). Further studies both in humans and mice are required to clarify 
-immune diseases. Our mice with 
-X reporter system could serve as 
-derived IL-10 in various auto
deficient for IL-10 in mast cell s
-mediated allergic disorder
stimulatory functions of mast cells and their 
effects of mast cells in the model
 
il10 in B 
-derived IL-10 in the 
 CD19-Cre mice were 
- dependent 
cently reported 
 was also shown by 
-
-immune diseases. 
 exhibit normal 
s (Kawakami et al., 
 of CHS. 
Mast cell-deficient mouse lines
to DNFB and urushiol. When the mice were engrafted with bone marrow cultured mast cells 
from wild type mice the enhanced ear inflammation was suppressed to normal levels
protection did not occur in mice transferred with mast cells deficient for 
al., 2007). These results points 
CHS response. However, these data solely rely on the adoptive transfer methods which suffer 
from inherent limitations. To validate these findings in a more appropriate system, we selectively 
knocked out the il10 gene in mast cells. 
mice with no difference observed in deleted and IL
contrary, the complete loss of IL
Our findings suggest that ma
dependent inflammatory response
with this finding, contact allergen
of IL-10 expression. The discrepant finding of 
introduced by the adoptive transfer procedure. 
3.4.3 DC-derived IL- 10
model of CHS 
It is well known that dendritic cells are i
immune responses which are central in the induction and maintenance of 
tolerance (Steinman et al., 2003). Earlier studies have documented the role of 
et al., 2008) and LCs (Bobr et al., 2010
IL-10 from LCs was shown to be important in the limitation of CHS (
Recently, it has been shown that dendritic cells engineered to overexpress IL
response (Besche et al., 2010).
In order to address this question, in an independent model 
one cellular source of IL-10 is involved in regulation
in DC. Conditional inactivation
PCR in spleen and ear skin. Upon, sensitization and challenge with the hapten (DNFB) the 
specific IL-10 mutants showed excessive ear inflammation marked by increased infiltrati
cells closely resembling the situation in 
, kitW/W-v and kitW-sh/W-sh showed enhanced ear swelling responses 
to the role of mast cell-derived IL-10 in negatively re
Surprisingly, we found normal CHS responses in 
-10 competent littermate controls. On the 
-10 as expected resulted in enhanced inflammatory responses. 
st cell-derived IL-10 is not required for restraining the T cell
s in the model of CHS (Dudeck et al., 2011). In 
-challenged ears of Vert-X reporter mice 
Grimbaldeston et al. may be due to artifacts 
 
 is relevant for immune suppression in the 
mportant initiators but also regulators of adaptive 
) in initiating the delayed hypersensitivity response.
 
and to investigate whether more than 
 of CHS, we selectively ablated 
 of the il10 gene in DCs was efficiently demonstrated by nested 
complete IL-10 deficiency. This data suggests that DCs 
 
, while 









Igyarto et al., 2009). 
-10 inhibit the CHS 




are important source of IL-10 limiting the 
is still unclear. Data from the 
dendritic cells during the efferent phase of CHS
possibility that IL-10 secreting DCs in the lymph node represent the essential source of IL
CHS. Future experiments will th
nodes draining contact allergen
Upcoming studies suggest that the Treg mediated suppression is achieved by modulating DC 
functions (Tang et al., 2006). 
has been shown by Kryczek et al.,
regulatory T cells have recently been reported as one mechanism for immune
regulation in CHS (Gorbachev et al., 2010). A possible mechanism is that the DC derived IL
may act in an autocrine fashion down
T cells anergic and thus achieving peripheral tolerance. However, further experiments are 
needed to understand the mechanisms of immune suppression. 
can serve as attractive targets for immunotherapeutic approache
3.5 Role of IL-10 from different cell types
inflammation  
3.5.1 Dispensable role of B cell
inflammation  
Previous studies have demonstrated that mice with complete deficiency of 
overwhelming immune responses to 
of chronic colitis (Kuhn et al., 1993; Rennick et al., 1997; Annacker et al., 2003). 
IL-10 mutant mice show a strong propensity to develop chronic colit
distinguishable from the disease in complete IL
in Roers et al., 2008). In line with these results, the essential role for T
restraining gut inflammation has been s
Manchester, personal communication
cells with the potential to produce IL
maintaining intestinal homeostasis 
CHS response. However, the mechanism of regulation 
IL-10 reporter mice showed a marginal production of IL
 in the ear tissue. One must consider the 
erefore address IL-10 production by different cell types in lymph 
-treated skin.  
The capacity of T regulatory cells to induce IL
 2006. Also, restricting DC priming functions by CD4
-regulating co-stimulatory and MHC molecul
With better understanding
s.  
 in restraining gut 
-derived IL- 10 in limiting intestinal 
intestinal bacteria that result in spontaneous development 
-10-/- deficient mice (Roers et al., 2004, reviewed 
 cell
hown in an inducible model of colitis (
). Furthermore, specialized population
-10 and TGF-β were found to be critical players in 











il10 gene show 
T cell-specific 
is that was not 
-   derived IL-10 in 
Werner Muller, 
s of T regulatory 
 
Asseman et al., 1999). Recent studies have revealed a
expression on regulatory T cells for mediating their suppressive f
(Murai et al., 2009). 
While regulatory T cells were widely suggested to suppress the dysregulated immune 
responses in the gut via IL-10 and TGF
been claimed to contribute to
Mizoguchi and colleagues have demonstrated earlier that B cells suppress colitis. Further 
characterization of regulatory B cell sub
potential for IL-10 secretion in these cells mediating suppression by down
inflammatory cascade associated with IL
polarized Th cell responses (Mizoguchi et al., 2002). In addition, adoptive transfer of m
lymph node B cells suppresses IBD through a mechanism that correlate
regulatory T cell subsets (Wei et al., 2005). In line with this, a recent study 
CD1dhiCD5+ (“B10”) regulatory B cells as an important source of IL
inflammation (Yanaba et al., 2011). 
We generated B cell-specific IL
development of IBD. These mice did not reveal any macroscopic or microscopic 
while, complete IL-10 ko and T cell
high incidence of IBD. Similar results were also obtained in 
(Trichuris muris infection; Werner Muller, Manchester, personal communication
together, our data suggest that B cell
and that the regulation of the intestinal immune system






 function for IL-10 in maintaining FoxP3 
unctions in the model of colitis 
-β dependent pathways, regulatory B cells have also 
 intestinal immune homeostasis via IL-10 
-sets has shown a high expression 
-1 and STAT3 activation rather than by altering 
-10 in suppressing gut 
 
-10 mutant mice and analyzed them for spontaneous 
-specific IL-10 ko mice housed in the same facility featured 
an inducible model of colitis 
-derived IL-10 is dispensable for limiting gut inflammation 
 is dependent on IL
will investigate the role of DC-derived IL-10 in regulating intestinal 
 
dependent pathways. 
of CD1d and a high 
-regulating the 
esenteric 
d with an increase in 
described 
signs of IBD 
). Taken 
-10 from other cellular 
3.6 Concluding remarks
 
The findings of this thesis, earlier reports from our group on phenotypes of ce
10 knock out mice as well as studies from other groups relying on different experimental 
systems all suggest that the cellular source of the cytokine critically determine its biological 
effects. The molecular mechanisms ensuring this cell type
understood. Most likely, IL-10 acts in a parac
vicinity of the cell, which releases the cytokine. The local restriction of biological effects of IL
could rely on cytokine gradients or on limited
Moreover, binding of IL-10 to structures of the extracellular matrix or on cellular surfaces may 
limit its diffusion. Importantly, the mechanisms of local confinement of IL
the biological effects of exoge
represent one reason for poor success of IL
















rine fashion and its effects remain confined to the 
 stability of the IL-10 proteins in inflamed tissues. 
-10 action might impede 
nous IL-10 administered for therapeutic purposes and might 






4 Materials and methods
4.1 Mice 
The IL-10FL line (Roers et al., 2004) was crossed with CD19
Mcpt5-Cre (Scholten et al., 2008) and CD11c
cell, mast-cell and DC-specific conditional IL
Jackson laboratory), IL-10 transcriptional reporter mice (Vert
mice were used. All animals used were on 
under specific pathogen-free (SPF) conditions at the “Experimental Centre” of the Medical 
Faculty Carl Gustav Carus, Dresden
was performed according to ins
4.2 Genotyping 
4.2.1 Isolation of genomic tail DNA
Mouse tail tips, about 0.5 cm in length, were incubated overnight at 56°C rocking in 500 
buffer (100 mM Tris, 0.2 M NaCl, 0.2% SDS, 5
Proteinase K (20 mg/ml, Fermentas). Undigested material was sedimented by centrifugation 
and the supernatant was poured into a fresh 1.5 ml micro centrifuge tube containing 500
isopropanol. The samples were mixed by inverting the tubes several times
DNA was pelleted by centrifugation and washed once with 70% ethanol. The air dried DNA 
pellet was dissolved in 125 µl of 1x TE buffer by incubating at 55°C shaking for at least 2 h. The 
DNA samples were then stored at 4°C.
 
4.2.2 Genotyp ing protocols
Mice were genotyped by PCR using 
were purchased from Metabion.
 
    PCR                                 Primer 
   
1. WT and IL-10 FL  for MCO 2: 5`




-Cre lines (Caton et al., 2007) to 
-10 mutants. In addition, WT mice (Charles River, 
-X) (Madan et al., 2009) and IL
the C57BL/6 background. The mice were housed 
 and Cologne animal facility. All animal experimentation 
titutional guidelines. 
 
 mM EDTA pH 8.5) supplemented with 5
 
 
a standard PCR program as specified below
  
name and sequence        
-CCA GCA TAG AGA GCT TGC ATT ACA-3`  
-GAG TCG GTT AGC AGT ATG TTG TCC AG -3`   
 
rt et al., 1997),        





. The precipitated 
. All primers 
PCR product size   
 WT: 480 bp 
  FL: 514 bp 
   
   
    PCR                                Primer 
 
2. CD19-Cre  CD19 CreUp 1 5`
 nls Cre Do 2 5`
 
 
3. Mcpt5-Cre  Mcpt5- CreUP: 5´ACA GTG GTA TTC CCG GGG AGT GT 
   Mcpt5- CreDO: 5´GTC AGT GCG TTC AAA GGC CA
 Mcpt5- Ex1DO3: 5’ TGA GAA GGG CTA TGA GTC CCA
 
4. CD11c-Cre  Forward: 5’
   Reverse: 5’
 
5. Vert-X reporter mice Primer 1:  
                                            Primer 2: GAGGAAATTGCATCGCATTGTCTGAGTAGGT
   Primer 3: CAAAGGCAGACAAACAATACACCATTCCCA
1. WT    
2. Vert-X heterozygotes  
3. Vert-X homozygotes  
 
6. IL-10-/-   IL10(-/-) UP            5´
 IL10(-/-) DO            5´
 
WT UP    5´
WT DO   5´
 
                                                                                         
Table 4.1 Table displays pr imer sequences and expected DNA fragment
lines. 
    
PCR program for typing (Vert
 
Table 4.2 Genotying PCR program for 
composition. All reagents for PCR were purchased fr om Fermentas.
Program     
step 
PCR 1 (primers 1 & 
3) 
1 2 min 94°C  
    
 2 15 sec 94°C  
3 30 sec 62°C  
4 45 sec 72°C  
    
 5 7 min 72°C  
6 pause 15°C  
    
 step 2-4: 35 cycles   
name and sequence        
-GCT GGG GCT CCC CTT TTC CTC T-3`   




 ACT TGG CAG CTG TCT CCA AG 3’  




Genotype pdts with primers (1&3)    Genotype pdts with 
  ~750 bp                               
  ~750 bp & ~3 kb band  
  ~3 kb band                 
-TAG GCG AAT GTT CTT CC-3´  
-CCT GCG TGC AAT CCA TCT TG-3´         
-AAC TTC TCA TGC TGG GAT CTG AGC T-3´  
-GTA AGA GCA GGC AGC ATA GCA GTG CT-3´ 
 
 size for dif
     
-X) IL-10 reporter  mice                 Reaction mix (1x)
  
IL-10 transcription al reporter mice and
 
    
PCR 2 (primers 2 & 3) 
2 min 94°C 
    
15 sec 94°C 
30 sec 60°C 
30 sec 72°C 
    
7 min 72°C 
pause 15°C 
    
    
10x PCR Buffer
25 mM MgCl2  
10 mM dNTP 
10 µM Primer (1 or 2)




 Probe DNA  
                                                                                                  
 PCR product size   
~1 kb; 700 bp faint band 
Wildtype: 224 bp  
Cre: 554 bp 
Cre: ~300 bp 
 
primers (2&3) 
 No Band 
 ~500 bp 
 ~500 bp 
 ~1300 bp 
                 ~750 bp 
ferent mouse 
 
 PCR reaction mix 
 5 µl 
5 µl 
1 µl 
 1 µl 
 1 µl 
 0.4 µl 




  2 µl 
Touchdown PCR: This protocol 




Reaction mix (1x): 
10x PCR buffer(Fermentas) 
10 mM dNTP (Fermentas) 
10 µM Forward Primer (Metabion)
10 µM Reverse Primer (Metabion)




Probe DNA  
    
   





and PCR reaction mixture composition was used in principle to 
IL-10 reporter mice. 
 Time Cycles  
95 4 min   
94 30 sec 
2  60 30 sec 
 72 45 sec 
94 30 sec 
2 58 30 sec 
72 45 sec 
94 30 sec 
2 56 30 sec 
72 45 sec 
94 30 sec 
34 54 30 sec 
72 45 sec 
72 10 min   




          
  








 28.6 µl 
35.0 µl 
  0.5 µl 
 
4.3 Procedures for animal
4.3.1 Reagents  
LPS from Escherichia coli serotype 055:B5 (Sigma
dissolved in sterile saline was used for i.p. injections. The phosphorothioate CpG 
oligodeoxynucleotide 1826, 5´
oligodeoxynucleotide 1982, 5´
were injected i.v. and s.c. in sterile saline.
was used for i.v. injection. 
 
4.3.2 Induction of contact hypersensitivity (CHS)
1-fluoro-2,4-dinitrobenzene (DNFB) from 
oxazolin-5-one (Oxazolone) from Sigma
Aldrich) mixed in the ratio of 4:1.
 
4.3.2.1 DNFB-induced
The mice were sensitized on day 0 by painting the shaved abdomen with 30 
DNFB in a 4:1 mixture of acetone and olive oil. Subsequently, the mice were challenged on day 
5 by application of 10 µl of 0.2% DNFB (vol/vol) in 4:1 mixture of a
side of one ear. Ear thickness was determined before sensitization and after allergen challenge 
for 4-6 consecutive days using an engineer’s caliper (Mitutoyo). This standard protocol was 
used for inducing CHS in various condit
mice unless otherwise specified.
In a different sensitization protocol (adopted from 
performed by painting the dorsal surface of the ears with 25 µl of 
consecutive days (day 0-2). Ear thickness measurement was done on days 0, 3 and 5 following 
sensitization. After subsequent reduction to the baseline ear thickness, the mice were 
challenged with a single administration of 25 µl of 
ears (day 22). Ear thickness was determined after allergen challenge for 4 days using an 
engineer’s caliper (Mitutoyo). Each ear was measured four times at each time interval with the 
mean of these values used for 
using the formula 
 experimentation 
-Aldrich) and LPS 
-TCC ATG ACG TTC CTG ACG TT
-TCC AGG ACT TCT CTC AGG TT-3’, (Metabion, Germany) 
 Poly (I:C) from Invivogen dissolved in sterile saline 
 
Sigma-Aldrich and 4-ethoxymethylene
-Aldrich were dissolved in acetone and olive oil 
 
 contact hypersensitivity 
cetone and olive oil to each 
ional IL-10 mutants and IL-10 transcriptional reporter 
 
Larson et al., 2007), DNFB
0.15% (vol/vol) 
0.15% (vol/vol) DNFB
analysis. The percent increment in ear thickness was calculated 
 
(S.typhi) from Sigma 
-3’ and the mock 
-2-phenyl-2-
(Sigma-
µl of 0.5% (vol/vol) 
-induced CHS was 
DNFB for three 
 at dorsal surface of 
 
ear thickness after challenge
% increase in ear thickness =  
  
and the student t-test was used to calculate the level of significance
    
4.3.2.2 Oxazolone- induced
Mice were sensitized with 25 µl
(4:1 v/v) applied for 2 consecutive days on 
were challenged by application of 10 µl of oxazolone solution (10 mg/ml) i
(4:1) to the right ear (5 µl on the dorsal side and 5 µl on the ventral side). The thickness of the 
central portion of each ear was m
engineer’s caliper (Mitutoyo). 
mean of these values used for analysis. This protocol was adopted from Yanaba et al., 2008. 
The percent increase in ear thickness was calculated using the above formula and level of 
significance was calculated using the student t
 
4.3.3 Monitoring mice for development 
disease (IBD) 
IL-10-/-, IL-10FL/FL CD19-Cre (SPF facility, Cologne) and IL
MTZ, Dresden) were assessed for gut inflammation in the spontaneous model of IBD. The 
animals were housed in the specific pathogen free (SPF) 
the Technical University Dresden
assessed for the development of rectal prolapse. 
fixed in formalin overnight. Paraffin sections were stained by haematoxylin and eo
staining) to quantify inflammation
 
4.4 Flow cytometry
4.4.1 Buffers and reagents
FACS buffer: 1x PBS, 0.5% (w/v) BSA (Serva), 2
 
 - thickness before challenge
                                                           
thickness before challenge 
. 
 contact hypersensitivity 
 of oxazolone (100 mg/ml, Sigma Aldrich) in acetone/olive oil 
the shaved abdomen. On day 5, sensitized mice 
easured at 24, 48, 72, and 96 h after challenge 
Each ear was measured four times at each time interval, with the 
-test. 
of i nflammatory bowel 
-10FL/FL CD11c-Cre mice (
facility at the University of Cologne or 
 and followed over a period of more tha




 mM EDTA in ddH2O  
 
         
                            100         
n acetone/olive oil 
using an 
SPF facility, 
n half a year and 
sin (H&E 
Liberase (Blendzyme 2) Roche #11 988 433 001 (10x):
10x blendzyme 2 was dissolved in 10
reconstituted following manufacturer’s instructions and 
enzyme was dissolved in 20
digesting two ears. 
Propidium iodide (Sigma): 1
concentration 0.5 µg/ml 
 Collagenase IV (Worthington Biochemical Corp., Lake wood, NJ): 
prepared before use for splenic digestion
BD Pharm Lyse (BD biosciences): Erythrocyte lysis buffer, 1:10 diluted in ddH
PBS: 10 mM Na2HPO4, 1.5 mM KH
HBSS (containing Ca and Mg) +25
HBSS with Ca and Mg, PAA #H15
Hepes 1M, Invitrogen #15630
DNase I grade II, from bovine pancreas: 
instructions (conc= 2U/µl). 20 
 
4.4.2 Antibodies for flow cytometry
specificity       target cells         host/isotype            clone              dye             
 
CD117            mast cells        Rat IgG2b 
                                                                   
CD19              B cells             Rat IgG2a 
 
Cd19           B cells             Rat IgG2a 
 
CD45R/B220  B cells,             Rat IgG2a 
           T cells, NK cells   
 
CD1d         leukocytes         Rat IgG2b 
 
 
CD5       mature T cells,     Rat IgG2a
      B subsets         
  
CD4             Mature T            Rat IgG2b 
                    cells, DC         
  
 ml HBSS buffer (conc: 28U/ml). The enzyme was 
stored in aliquots at 
 ml of 1x HBSS buffer and 1-2 ml of this solution was used for 
 mg/ml stock solution in ddH2O, working diluti
2 mg/ml in PBS, freshly
 
2PO4; 2.6 mM KCl, 136 mM NaCl, pH 7.4
 mM Hepes: 
-008  500 ml HBSS 
-056   12.5 ml HEPES 
Reconstituted according to the manufacturer’s 
µl aliquots were prepared and used for digesting two ears.
 
  final dilution            Source       
κ             2B8             APC                 1:500  
 
κ           1D3          PE                  1:100            eBiosciences
κ        eBio1D3         PE-Cy7      1:100
κ        RA3-6B2       APC-Cy7          1:200               Biolegend                                     
κ 1Β1               PE        1:200 
 κ          53-7.3           APC                1:100             eBiosciences
κ            GK1.5           PE                 1:200             eBiosciences
 
-20°C. 100 µl of 






 eBiosciences  
  
 eBiosciences  




specificity      target cells         host/isotype           clone              dye               final dilution            Source 
 
F4/80          Macrophages   Rat IgG2a 
 
F4/80      Macrophages    Rat IgG2a
      
CD8      T cells,              Rat IgG2a
      intraepithelial  
                  lymphocytes,  
     DCs   
  
CD3        T cells           Golden 
                                          Hamster IgG  
 
CD45      Haematopoietic   Rat IgG2b
                 cells  
 
 
NK1.1 NK cells, T subsets    Mouse IgG2a
 
 
CD1d leukocytes           Rat IgG2b 
 
 
CD45 Haematopoieitc          Rat IgG2a
 cells 
 
IgE Reacts with the ε        Rat IgG1
 heavy chain of  
             mouse IgE 
 
CD8 T cells,            Rat IgG2a
 Intraepithelial 
lymphocytes, DCs 
    
Cd19        B cells                Mouse IgA, 
  
 
CD45R/B220  B cells ,           Rat IgG2a
                       T cells,  
           NK cells 
 
F4/80  Macrophages         Rat IgG2a
κ             BM8           APC-Cy7    1:50 
 κ               BM8               PE                1:100 
     
 κ             53-6.7           PE-Cy7           1:200             
       
syrian        eBio500A2          PE    1:100 
 
 κ               30−F11           PE                1:200
 κ  PK136          APC    1:100 
κ     1Β1              FITC           1:50  
 κ  RA3-6B2      APC/Cy7     1:100 
 κ                 23G3           PE    1:50             
 κ               53-6.7         AF488      1:200
 
      
κ              MB19-1         FITC      1:100
 κ                RA3-6B2       FITC          1:200            
 κ                        BM            FITC     1:100 
 
 
     eBiosciences 
     eBiosciences 
    eBiosciences 
               eBiosciences 
    eBiosciences 
               eBiosciences 
              eBiosciences                               
       Biolegend  
    eBiosciences
   eBiosciences 
  eBiosciences  
 eBiosciences 
  eBiosciences 
 
 
specificity    target cells           host/isotype           
 
mPDCA   plasmacytoid          Rat IgG2b        
    DC 
 
CD3     T cells         Armenian
 
CD11c     DC, IEL,        Armenian                  
                Activated            Hamster IgG   
            T cells    
 
FcεR1α     Mast cells,          Armenian
                 Basophils     Hamster IgG             
 
CD11c     DC, IEL,  Armenian Hamster IgG
                activated  
                T cells 
 
CD3     T cells           Armenian Hamster IgG     145
 
 




The hematopoietic cells in the cell suspensions (described below) were identified by staining for 
specific cell surface markers. Unspecific 
part of the heavy chain was avoided by blocking with anti
against the FcγIII and the Fcγ
the antibodies listed in table 4.4 in 100 
steps, propidium iodide was added (final concentration 0.5 





         clone              dye       final dilution  
 JF05-1C2.4.1      PE           1:11      
 hamster IgG      145-2C11      APC         1:100         
 N418              PE-Cy7      1:100             
 
              MAR1               PE            1:300 
 
  N418           APC           1:100 
-2C11     FITC       1:100 
 
binding of antibodies to Fc receptors via their invariable 
-CD16/32 (eBioscience) directed 
II receptor, respectively. Subsequently, cells were incubated
µl FACS buffer for 30 min on ice. After two washing 
µg/ml) for exclusion 
 
      Source  
        Miltenyi Biotec 
   eBiosciences 
  Biolegend 
     eBiosciences 




of dead cells. 
 
4.4.4 Single cell suspensions
4.4.4.1 Peritoneal lavage
The mice were euthanized and the outer skin 
the peritoneal lining. A small hole 
stretched and held tightly. Using the pasteur pipette or glass pipette the peritoneal cavity was 
flushed with 5 ml cold FACS buffer (3x) and the cells were collected in tubes. Cells were 
sedimented and the pellet was resuspended in
 
4.4.4.2 Spleen cell suspension
The spleen was removed from the animal, smashed in a petri dish containing DMEM medium or 
FACS buffer using a plunger of a 2 ml syringe and rubbed through a 70 
petri dish and the cell strainer were washed once with buffer and the resulting
centrifuged at 1200 rpm for 5 min. The cell pellet was resuspended and incubated for 5 min at 
RT in 5 ml (1:10 dilution) of BD Pharm Lyse solution in order to lyse
additional centrifugation, cells were resuspended in 10 ml FACS buffer and finally filtered 
through a 40 µm strainer. 
 
4.4.4.3 Skin cell suspension
Two ears were excised from adult mice. The hair was removed and the tissue was minced 
thoroughly in 2 ml micro ce
(incubated at 37°C water bath; stock concentration=  28U/ml) was added and
h 20 min at 37°C in a thermomixer (1400
suspensions were vortexed at intervals of 30
over a 40 µm cell strainer and centrifuged at 1200 rpm for 5 min at 4°C. The cel
resuspended in 2-3 ml FACS buffer and filtered over a 30 
centrifuged at 1200 rpm for 5 min at 4°C and resusp ended in 2
 
4.4.4.4 Enrichment of splenic B cells
For sorting regulatory B10 cells, the splenic cells were enriched for B cells using mouse
microbeads (Miltenyi Biotec) and MS 
the spleen (see section 4.4.4.2) were prepared and the cell numbers were determined using the 
 
 
of the abdomen was cut open without damaging 
was made with sharp scissors and the peritoneal layer was 
 FACS buffer. 
 
 
ntrifuge tubes using scissors. To this, 1 
 rpm speed). During incubation, the skin cell 
-40 minutes. The suspensions were then filtered 
µm strainer. Cells were fina
-3 ml FACS buffer.
 
or LS columns (Miltenyi Biotec). Single cell suspensions of 
 
µm cell strainer. The 
 suspension was 
 erythrocytes. After 
ml of warm liberase 
  incubated     for 1 






cell counting chamber. For up
in the total volume of 100 µl and incubated for 15 minutes at 2
and resuspended in 500 µl of FACS buffer. Then the cells were subjected to magnetic 
separation. The column was placed in the magnetic field of a MACS separator and ri
appropriate volume of FACS buffer. The cell suspension was allowed to pass 
column using a 30 µm sieve. The column was then washed thrice with FACS buffer and the flow 
through was collected in separate tubes. This 
Then the column was removed from the separator and appropriate amount of FACS buffer was 
added and immediately the magnetically labeled cells were flushed out by firmly pushing
plunger into the column (mostly B cells). The 
resuspended in suitable volume of FACS buffer. The enriched fraction and flow through were 
stained for different surface markers and analyzed by FACS.
 
4.4.4.5 Enrichment of splenic 
In order to achieve high purity of 
enriched for DCs using the magnetic separation method (Miltenyi
digested enzymatically using collagenase IV (Worthington Biochemical Corp.,) (conc: 2
The spleen was cut into small pieces using surgical scissors and incubated in 
containing collagenase in PBS for 30 minutes at 37°C. Following incubation, the cells were 
passed through a 70 µm cell sieve
were determined and the cells were 
per 108 total cells in the total volume of 500
suspension was washed and resuspended in 500
separator (Miltenyi Biotec) was used to magnetically separate the labeled 
was placed on the MiniMacs separator unit. T
FACS buffer. The cell suspens
column. The flow through containing 
washing the column three times with FACS buffer.
the column with FACS buffer and immediately applying the plunger to flush out the magnetically 
labeled population (mostly DCs
different surface markers and analyzed by FACS.
 to 107 cells 10 µl of CD19 microbeads (1:10 dilution) was added 
-8°C . The cells were then washed 
was the unlabelled fraction (mostly non
cell numbers were determined, washed and 
 
dendritic cells 
the DC population, splenic single cell suspensions were 
 Biotec
, and washed and resuspended in FACS buff
incubated with 100 µl pan DC micro beads
 µl FACS buffer for 15 minutes at 4
 µl FACS buffer. A MS column 
he column was rinsed with appropriate volume of 
ion was passed through a 30 µm cell sieve and 
non-labeled fraction (mostly non-DCs
 The labeled fraction was 







). The spleen was 
 mg/ml). 
a petri dish 
er. Cell numbers 
 (Miltenyi Biotec) 
-8°C. The cell 
and Mini Macs 
DCs. The MS column 
loaded on to the 
) was collected by 
released by rinsing 
4.5 Cell sorting 
4.5.1 Sorting of c onventio
Spleen cell suspensions were subjected to erythrocyte lysis for depletion of erythrocytes. B cells 
were enriched immunomagnetically using CD19 microbeads as explained in section 4.4.4.4.
The unlabelled fraction was stained for T cells using anti
was stained with anti-CD19, anti
purchased from ebiosciences or Biolegend. 
final dilution for monoclonal antibodies were shown in table 4.4. 
B10 cells and T cells were sorted using 
 
4.5.2 Sorting of mast cells from
Cells from peritoneal lavage and ear skin were isolated as mentioned in section 4.4.4.1 and 
4.4.4.3, respectively. Mast cells in peritoneal lavage were stained 
markers. Macrophages and B cells in lavage were stained 
respectively. Ear skin mast cells were stained 
CD3 marker. Single mast cells, macrophages,
(BD Biosciences, CRTD, Dresden). All antibodies were purchased from eBiosciences or 
Biologend. The specificity, target cells, isotype, clone, dye and final dilution for monoclonal 
antibodies were shown in table 
 
4.5.3 Sorting of DC from 
Splenic single cell suspensions were prepared as mentioned in section 4.4.4.2.
were enriched immunomagnetically using the pan CD11c microbeads 
described in section 4.4.4.5. The plasmacytoid and conventional DC were stained using anti
mouse mPDCA and anti-mouse CD11c monoclonal antibody 
respectively). T and B cells were stained 
respectively (eBiosciences). Single 




nal and Regulatory B10 B cell
-CD3 antibody. The enriched fraction 
-CD1d and anti-CD5 antibodies. All antibodies mentioned were 
The specificity, target cells, isotype, clone, dye and 
Conventi
a FACS ARIA (BD Biosciences, MTZ, Dresden).
 peritoneal lavage and ear skin tissue
for CD117 and IgE surface 
for F4/80 and B220
for c-kit and FcεR. T cells were 
 T and B cells were sorted using 
4.4. 
spleen and ear skin tissue 
(Miltenyi Biotec 
using anti-CD3 and anti-CD19 surface markers





onal and regulatory 
 
 
 surface markers, 
stained using anti-
a FACS ARIA 
 The DC subsets 




DCs), T and B 
In addition, ear skin dendritic cells were also sorted. Ear skin suspensions were prepared as 
described in section 4.4.4.3. Ear skin 
CD11c monoclonal antibodies. T cells were stained using anti
CD3 monoclonal antibodies. Single 
Biosciences, CRTD, Dresden). All antibodies were purchased from eBiosciences or Biolegend.
The specificity, target cells, isotype, clone, dye and final di
shown in table 4.4. 
 
4.6 Nested PCR 
The nested PCR technique is a modification of polymerase chain reaction intended to achieve 
very high sensitivity i.e. to amplify very low abundant targets with high numbers of cycle
competition between the desired specific amplicon and non
second round of amplification using primers binding internal to the first round primers solves this 
problem since non-specific products are unlikely to provide ta
(‘‘nested’’) primers. This strategy allows performance of very high numbers of cycles and thus, 
amplification of even single target molecules.
 
Nested PCR as described here comprises of two rounds of polymerase chain reaction usin
three primers for each round of PCR. The first round of PCR uses the primers labeled FP1, MP1 
and RP1 designed to bind sequences flanking the loxP site of the exonic sequence of the 
gene. The second round PCR uses primers designated as FP2, MP2 and 
sequences of the first round primer binding sites. During the first round polymerase chain 
reaction the intended target is amplified which subsequently serves as a template for the 
second round amplification thus reducing the chances
increasing the fidelity of the amplified products. We used this technique to selectively amplify 
the il10 gene locus from single sorted hematopoietic cells from various IL
mutants.   
 
4.6.1 Primers fo r selective amplification of 
PCR: 
The following primer sets were used for the first (FP1, MP1 and RP1) and second round PCR 
(FP2, MP2 and RP2) PCR, respectively
DCs were stained using anti-mouse CD45
-mouse CD
DCs and T cells were sorted using 
lution for monoclonal antibodies were 
-specific products is limiting. A 
rget sites for the second 
 
 of amplifying non
the il10 locus by nested 
 (see figure 2.12). 
 
 and anti-mouse 
45 and anti-mouse 





RP2 that bind internal 
-specific products and 
-10 conditional 
 
First round PCR: 
FP1- 5’ ATTACGGGAAGATATAAGAGGTGCTG 3’
MP1- 5’ GACCTGTACTTACTGCACGGTGA 3’
RP1 – 5’ AAGTTAGACCCAGGCCCGGT 3’
 
Second round PCR: 
FP2 -5’ CGGGAAGATATAAGAGGTGCTGC 3’
MP2 -5’ GTACTTACTGCACGGTGATAGCC 3’
RP2 -5’ GTTAGACCCAGGCCCGGTCT 3’
 
4.6.2 Protocol for nested PCR:
Single cells were sorted into 0.5
buffer. The cells were spun down briefly and subjected to lysis by incubating with proteinase
(0.25 mg, Fermentas) at 50°C for 2
the tubes were incubated for 10 minutes at 95°C in a thermomixer at a speed of 700
inactivate the proteinase K a
reaction mixture was added to each tube
The recommended order for adding the ingredients of PCR reaction mix is deoxynucleotides 
(dNTPs), 10x Taq buffer (Fermentas) containing magnesium chloride (MgCl
(Metabion), distilled H2O and Taq polym
composition and the recommended PCR conditions for amplification are described below. 
 
4.6.2.1 PCR reaction mixture and amplification cond itions
 
Reaction mix for first round PCR: (1x)
10x Taq-Buffer (Fermentas) 
dNTP (10 mM)  
Primer FP1 (10 µM)  
Primer MP1 (10 µM)  
Primer RP1 (10 µM)  
Enzyme (5U/µl), (Fermentas) 
Distilled Water   
    
Total volume    








 ml thin walled PCR tubes containing 20
 h in a thermomixer at a speed of 700
ctivity. The content was spun down briefly and the polymerase 
. Filter/barrier tips were used to avoid contamination. 
erase enzyme (Fermentas). The reaction mixture 
 
 3 µl 
 0.625 µl 
 0.083 µl 
 0.083 µl 
 0.083 µl 
 0.5 µl 
 25.6 µl 
---------------------------- 
 30.0 µl 
---------------------------- 
 
 µl of 1x Dream Taq 
 K 
 rpm. Following this, 




Aliquot 30 µl of the reaction mix to the tubes containing single cells in 20 µl of 1x Dream Taq 
buffer. All the reagents were added in the recommended order except the Taq polymerase 
enzyme added during the pause step of the PCR reaction.
Reaction mix for second round PCR: (1x)
10x Taq buffer (Fermentas) 
dNTP (10 mM)  
FP2 (10 µM)    
RP2/MP2 (10 µM)  
Taq enzyme (5U/µl), (Fermentas)
Distilled Water   
DNA    
    
Total    
    
PCR conditions: 
First Round PCR:  
Step    Temp  
   1   95°C  
   2   80°C  
   3   72°C  
   4   95°C  
   5   60°C  
   6   72°C  
   7   72°C  
   8   15°C  
 
Second Round PCR:  
Step   Temp  
   1   95°C  
   2   72°C  
   3   95°C  
   4   95°C  
   5   65°C  
   6   72°C  
   7   72°C  




   3.5 µl 
   0.7 µl 
   0.7 µl 
   0.7 µl 
   0.35 µl 
   28.6 µl 
   1.0 µl (template from first round PCR)
  ------------------------- 
   35 µl 
  -------------------------- 
  Time 
  3 min 
  pause (Add Dream Taq enzyme)
  1 m 30 sec 
  30 sec 
  45 sec 
  2 min  Go to Step 4, 35x
  5 min 
  Unendl 
  Time 
  3 min 
  90 sec 
  2 min 
  30 sec 
  45 sec 
  2 min  Go to Step 4, 44x
  5 min 







The PCR products were visualized by gel electrophoresis in 
contamination. 
4.6.2.2. Gel elution and DNA sequencing
Following nested PCR, the PCR products were run on a 2% DNA agarose gel. The bands were 
visualized and excised under the UV
the agarose gel volume. The excised gel fragments were processed using 
extraction kit (Fermentas). The
8.5) and then sequenced (Seqlab, Gottingen).
4.7 Multiplex luminex assay
In order to measure the serum 
following LPS, CpG oligodeoxynucleotides
cytokine measurement method. 
Figure 4.1 Principle of multiplex assay (figure adopted from 
(I) Multiplex bead populations of defined colors
particular cytokine (II) Capture antibody binds cytokine/chemokine of interest 




-transilluminator. The bands were cut precisely to minimize 
 DNA was dissolved in the elution buffer (10
  
 
concentrations of pro-inflammatory cytokine
 or Poly(I:C) challenge, we used the multiplex 
The principle of the multiplex assay is shown in figure 4.1
lucerna-chem.ch
 are coated with capture antibody 
(IV) Bead intensity and reporter signals are 
 
 to avoid 
the GeneJET gel 
 mM Tris-HCl, pH 




specific for one 
(III) Fluorescent labeled 
 
The B cell-specific IL-10 mutant mice were challenged with LPS, CpG 
Poly(I:C). Following challenge
10 minutes and serum aliquots were stored at 
various pro-inflammatory cytokine and chemokine levels. The standards were prepared 
according to the manufacturer’s instructions and the cytokine levels in unknown samples were 
estimated based on standard values (Bio
4.8 Histology  
Colonic and caecum samples of IL
were fixed in formalin overnight and 
haematoxylin and eosin (H & E staining) using standard staining pr
scored for severity of inflammation, ulceration and edema.
Following s.c. CpG injection, the inflamed skin lesion of IL
specific IL-10 mutant mice were 
sections were stained with haematoxylin and eosin staining (H & E staining). 
4.9 Statistics 
Statistical analysis was done using student´s t












, tail blood samples were collected, centrifuged at 1200 rpm for 5
-20°C. The serum samp
-rad). 
-10-/-, B cell-specific IL-10 mutant mice (IL
paraffin embedded. 6 µm sections were stained with 
ocedures. The sections were 
 
-10-/-, mast-
excised, fixed in formalin and embedded in
-test (for two groups). Graphs presented in this 




les were analyzed for 
-10FL/FL CD19- Cre+) 
cell specific and DC- 
 paraffin. 6 µm 
 
5 Abbreviations  
ACD   acute contact dermatitis
APC   antigen presenting cells
BCR   B cell receptor
bp   base pair
BSA    bovine serum albumin
CD   cluster of differentiation
CD   Crohn’s disease
CHS   contact hypersensitivity
CIA   collagen induced arthritis
Cre    causes recombination
DC   dendritic 
DNA   deoxyribonucleic acid
DNCB   dinitrochlorobenzene
DNFB   1-fluoro
dNTP   deoxyribonucleoside triphosphate
E. coli    Escherichia coli
EAE   experimental autoimmune encephalomyelitis
EDTA   ethylene diamine tetra acetate
eGFP    enhanced green fluorescent protein
FACS   fluorescent activated cell sorting
FasL   Fas ligand
FoxP3   forkhead box P3
GM-CSF  Granulocyte macrophage colony
H & E   haematoxylin and eosin
h   hour 
HBSS   Hank's buffered salt solution
HEPES  2 -(4 - (2
i.p.   intra-peritoneal
i.v.   intra-venous
IBD   inflammatory bowel disease
Ig   immunoglobulin
IL-10   Interleukin
IRES   internal ribosomal entry site
Ko   knock out
LC   langerhan
loxP                            locus of crossing (X)
LPS   lipopolysaccharide
MACS    magnetic activated cell sorting
MCMV   murine cytomegalovirus
MHC   major histocompatibility complex












































NK   natural killer
pA   polyadenylation 
PBS   phosphate buffered saline
PCR   polymerase chain reaction
%   percentage
rpm       rotation per minute
RT   room temperature
s.c.   sub cutaneous
S.typhi   Salmonella typhimurium
SD   standard deviation
SDS   sodium dodecylsulfate
SIT   specific immunotherapy
SLE   systemic lupus erythematosus
SPF   specific pathogen free
TCRα   T cell receptor alpha
TE   Tris-EDTA
TGF-β   transforming growth factor beta
TLR   toll like receptor
TNCB   trinitrochlorobenzene
TNF-α   tumor necrosis fa
Treg   T regulatory
Tris   Tris-(hydroxymethyl
U    unit 
UC   Ulcerative colitis
UTR   untranslated region
vol/vol   volume/volume
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and in myeloid DC. 
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activate the il10 gene with high efficiency in mast cells of 
 in other cell types. 
the regulation of local immune responses to 
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-dependent inflammatory responses
 local immune responses to TLR ligand
-10 are determined by the cellular source of the cytoki
 
lation of inflammatory 
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